<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome - Bond, DM - 2017 | Cochrane Library</title> <meta content="Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome - Bond, DM - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004735.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome - Bond, DM - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004735.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004735.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome" name="citation_title"/> <meta content="Diana M Bond" name="citation_author"/> <meta content="Kolling Institute of Medical Research, University of Sydney" name="citation_author_institution"/> <meta content="diana.bond@sydney.edu.au" name="citation_author_email"/> <meta content="Philippa Middleton" name="citation_author"/> <meta content="Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute" name="citation_author_institution"/> <meta content="Kate M Levett" name="citation_author"/> <meta content="David P van der Ham" name="citation_author"/> <meta content="Martini Hospital Groningen" name="citation_author_institution"/> <meta content="Caroline A Crowther" name="citation_author"/> <meta content="Sarah L Buchanan" name="citation_author"/> <meta content="Royal North Shore Hospital" name="citation_author_institution"/> <meta content="Jonathan Morris" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD004735.pub4" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/03/03" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004735.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004735.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004735.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cesarean Section [statistics &amp; numerical data]; Chorioamnionitis [epidemiology]; Delivery, Obstetric [*methods]; Fetal Death; *Fetal Membranes, Premature Rupture; Gestational Age; Intensive Care Units, Neonatal [statistics &amp; numerical data]; Labor Onset; Length of Stay [statistics &amp; numerical data]; Perinatal Mortality; Premature Birth; Randomized Controlled Trials as Topic; Respiration, Artificial [statistics &amp; numerical data]; Respiratory Distress Syndrome, Newborn [epidemiology, prevention &amp; control]; Sepsis [epidemiology, prevention &amp; control]; *Watchful Waiting" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004735.pub4&amp;doi=10.1002/14651858.CD004735.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="PSzzz2OT";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004735\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004735\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","th","ko","ms","ja","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004735.pub4",title:"Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks\u0027 gestation for improving pregnancy outcome",firstPublishedDate:"Mar 3, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PSzzz2OT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004735.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004735.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004735.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004735.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004735.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004735.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004735.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004735.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004735.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004735.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15740 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004735.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-abs-0007"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0143"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0091"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-sec-0137"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/appendices#CD004735-sec-0148"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/table_n/CD004735StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/table_n/CD004735StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Diana M Bond</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0003">Philippa Middleton</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0004">Kate M Levett</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0005">David P van der Ham</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0006">Caroline A Crowther</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0007">Sarah L Buchanan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information#CD004735-cr-0008">Jonathan Morris</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information/en#CD004735-sec-0155">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 03 March 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004735.pub4">https://doi.org/10.1002/14651858.CD004735.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004735-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004735-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004735-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004735-abs-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004735-abs-0005">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004735-abs-0004">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004735-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD004735-abs-0002">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004735-abs-0001" lang="en"> <section id="CD004735-sec-0001"> <h3 class="title" id="CD004735-sec-0001">Background</h3> <p>Current management of preterm prelabour rupture of the membranes (PPROM) involves either initiating birth soon after PPROM or, alternatively, adopting a 'wait and see' approach (expectant management). It is unclear which strategy is most beneficial for mothers and their babies. This is an update of a Cochrane review published in 2010 (Buchanan 2010). </p> </section> <section id="CD004735-sec-0002"> <h3 class="title" id="CD004735-sec-0002">Objectives</h3> <p>To assess the effect of planned early birth versus expectant management for women with preterm prelabour rupture of the membranes between 24 and 37 weeks' gestation for fetal, infant and maternal well being. </p> </section> <section id="CD004735-sec-0003"> <h3 class="title" id="CD004735-sec-0003">Search methods</h3> <p>We searched Cochrane Pregnancy and Childbirth's Trials Register (30 September 2016), and reference lists of retrieved studies. </p> </section> <section id="CD004735-sec-0004"> <h3 class="title" id="CD004735-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing planned early birth with expectant management for women with PPROM prior to 37 weeks' gestation. We excluded quasi‐randomised trials. </p> </section> <section id="CD004735-sec-0005"> <h3 class="title" id="CD004735-sec-0005">Data collection and analysis</h3> <p>Two review authors independently evaluated trials for inclusion into the review and for methodological quality. Two review authors independently extracted data. We checked data for accuracy. We assessed the quality of evidence using the GRADE approach. </p> </section> <section id="CD004735-sec-0006"> <h3 class="title" id="CD004735-sec-0006">Main results</h3> <p>We included 12 trials in the review (3617 women and 3628 babies). For primary outcomes, we identified no clear differences between early birth and expectant management in neonatal sepsis (risk ratio (RR) 0.93, 95% confidence interval (CI) 0.66 to 1.30, 12 trials, 3628 babies, evidence graded moderate), or proven neonatal infection with positive blood culture (RR 1.24, 95% CI 0.70 to 2.21, seven trials, 2925 babies). However, early birth increased the incidence of respiratory distress syndrome (RDS) (RR 1.26, 95% CI 1.05 to 1.53, 12 trials, 3622 babies, evidence graded high). Early birth was also associated with an increased rate of caesarean section (RR 1.26, 95% CI 1.11 to 1.44, 12 trials, 3620 women, evidence graded high). </p> <p>Assessment of secondary perinatal outcomes showed no clear differences in overall perinatal mortality (RR 1.76, 95% CI 0.89 to 3.50, 11 trials, 3319 babies), or intrauterine deaths (RR 0.45, 95% CI 0.13 to 1.57, 11 trials, 3321 babies) when comparing early birth with expectant management. However, early birth was associated with a higher rate of neonatal death (RR 2.55, 95% CI 1.17 to 5.56, 11 trials, 3316 babies) and need for ventilation (RR 1.27, 95% CI 1.02 to 1.58, seven trials, 2895 babies, evidence graded high). Babies of women randomised to early birth were delivered at a gestational age lower than those randomised to expectant management (mean difference (MD) ‐0.48 weeks, 95% CI ‐0.57 to ‐0.39, eight trials, 3139 babies). Admission to neonatal intensive care was more likely for those babies randomised to early birth (RR 1.16, 95% CI 1.08 to 1.24, four trials, 2691 babies, evidence graded moderate). </p> <p>In assessing secondary maternal outcomes, we found that early birth was associated with a decreased rate of chorioamnionitis (RR 0.50, 95% CI 0.26 to 0.95, eight trials, 1358 women, evidence graded moderate), and an increased rate of endometritis (RR 1.61, 95% CI 1.00 to 2.59, seven trials, 2980 women). As expected due to the intervention, women randomised to early birth had a higher chance of having an induction of labour (RR 2.18, 95% CI 2.01 to 2.36, four trials, 2691 women). Women randomised to early birth had a decreased total length of hospitalisation (MD ‐1.75 days, 95% CI ‐2.45 to ‐1.05, six trials, 2848 women, evidence graded moderate). </p> <p>Subgroup analyses indicated improved maternal and infant outcomes in expectant management in pregnancies greater than 34 weeks' gestation, specifically relating to RDS and maternal infections. The use of prophylactic antibiotics were shown to be effective in reducing maternal infections in women randomised to expectant management. </p> <p>Overall, we assessed all 12 studies as being at low or unclear risk of bias. Some studies lacked an adequate description of methods and the risk of bias could only be assessed as unclear. In five of the studies there were one and/or two domains where the risk of bias was judged as high. GRADE profiling showed the quality of evidence across all critical outcomes to be moderate to high. </p> </section> <section id="CD004735-sec-0007"> <h3 class="title" id="CD004735-sec-0007">Authors' conclusions</h3> <p>With the addition of five randomised controlled trials (2927 women) to this updated review, we found no clinically important difference in the incidence of neonatal sepsis between women who birth immediately and those managed expectantly in PPROM prior to 37 weeks' gestation. Early planned birth was associated with an increase in the incidence of neonatal RDS, need for ventilation, neonatal mortality, endometritis, admission to neonatal intensive care, and the likelihood of birth by caesarean section, but a decreased incidence of chorioamnionitis. Women randomised to early birth also had an increased risk of labour induction, but a decreased length of hospital stay. Babies of women randomised to early birth were more likely to be born at a lower gestational age. </p> <p>In women with PPROM before 37 weeks' gestation with no contraindications to continuing the pregnancy, a policy of expectant management with careful monitoring was associated with better outcomes for the mother and baby. </p> <p>The direction of future research should be aimed at determining which groups of women with PPROM would not benefit from expectant management. This could be determined by analysing subgroups according to gestational age at presentation, corticosteroid usage, and abnormal vaginal microbiological colonisation. Research should also evaluate long‐term neurodevelopmental outcomes of infants. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004735-abs-0007" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004735-abs-0007">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004735-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004735-abs-0015">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004735-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004735-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD004735-abs-0013">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004735-abs-0011">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004735-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD004735-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD004735-abs-0010">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004735-abs-0007" lang="en"> <h3>Is it better for the baby to be born immediately or wait for labour to start if the waters break without contractions before 37 weeks of pregnancy? </h3> <p><b>What is the issue?</b> </p> <p>If a pregnant woman's waters break without contractions before 37 weeks of pregnancy there are two options: for the baby to be born as soon as possible, or to wait for labour to start naturally. We need to carefully look at the risks and benefits of both options. </p> <p><b>Why is this important?</b> </p> <p>Being born too early can increase the chance of problems linked to prematurity, such as breathing difficulties and longer stays in the neonatal intensive care unit. However, staying in the womb may cause infections for both mother and baby that can lead to serious health problems and even death. This review aims to find out which is the best option. </p> <p><b>What evidence did we find?</b> </p> <p>We included 12 trials that involved 3617 women with preterm prelabour rupture of the membranes. Women were randomly selected to either early birth or expectant management (wait for birth).The women were between 25 to 37 weeks of pregnancy. The studies happened in 16 countries between 1977 and 2013. Overall, the 12 studies were assessed as being at low or unclear risk of bias and the evidence was of moderate to high quality. </p> <p>We found no difference in the rate of infant infection or infant death before birth between the two groups. However, early birth increased the risk of infant death after birth, as well as breathing problems, with the newborn needing extra help to breathe. The babies of women who had a planned early birth were more likely to be admitted to neonatal intensive care, and were born earlier than babies of women who waited to give birth. Early birth also increased the rate of caesarean section, induction of labour and the risk of infection of the lining of the womb but decreased the risk of infection in the membranes. Women had a longer hospital stay if they were randomised to waiting. </p> <p><b>What does this mean?</b> </p> <p>In women whose waters break before 37 weeks of pregnancy, waiting for labour to begin naturally is the best option for healthier outcomes, as long as there are no other reasons why the baby should be born immediately. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004735-sec-0143" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004735-sec-0143"></div> <h3 class="title" id="CD004735-sec-0144">Implications for practice</h3> <section id="CD004735-sec-0144"> <p>Current evidence does not demonstrate a difference in neonatal sepsis between women who give birth immediately or are managed expectantly in preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation. Early planned birth is associated with an increase in the incidence of neonatal respiratory distress syndrome, neonatal mortality, endometritis, induction of labour, and the likelihood of birth by caesarean section, and a decreased incidence of chorioamnionitis. In pregnancies complicated by preterm premature rupture of the membranes a policy of expectant management with careful observation is associated with better outcomes for the mother and baby. </p> </section> <h3 class="title" id="CD004735-sec-0145">Implications for research</h3> <section id="CD004735-sec-0145"> <p>Future randomised trials should be adequately powered to evaluate the effect of the different management strategies on long‐term childhood health, behaviour and cognitive outcomes. Also, future research should be aimed at identifying women with PPROM who would not benefit from expectant management by comparing gestational age at presentation, corticosteroid use and abnormal vaginal microbiological colonisation in both groups. An independent participant data analysis could be considered to address these differences. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004735-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004735-sec-0043"></div> <div class="table" id="CD004735-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with preterm prelabour rupture of membranes prior to 37 weeks' gestation<br/> <b>Settings:</b> USA, the Netherlands, Mexico, Albania, Australia, New Zealand, Argentina, South Africa, Brazil, UK, Norway, Egypt, Uruguay, Poland, and Romania<br/> <b>Intervention:</b> planned early birth<br/> <b>Comparison:</b> expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Planned early birth</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal infection/sepsis</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.66 to 1.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3628<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (24 to 48) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal respiratory distress syndrome</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> <br/> (1.05 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3622<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>109 per 1000</b> <br/> (89 to 131) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Need for ventilation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.27</b> <br/> (1.02 to 1.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2895<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>86 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> <br/> (88 to 136) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Admission to neonatal intensive care</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> <br/> (1.08 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2691<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>428 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>497 per 1000</b> <br/> (462 to 531) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Caesarean section</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> <br/> (1.11 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3620<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>172 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>217 per 1000</b> <br/> (191 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chorioamnionitis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b> <br/> (0.26 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1358<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 1000</b> <br/> (27 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay (maternal)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay (maternal) in the expectant group was<br/> <b>7.6 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay (maternal) in the early birth group was <b>1.75 days lower</b> <br/> (2.45 to 1.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐1.75</b> (‐2.45 to ‐1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2848<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide confidence interval crossing the line of no effect, and the lines of appreciable benefit and harm.<br/> <sup>2</sup>Some statistical heterogeneity (I² = 48%).<br/> <sup>3</sup>Statistical heterogeneity: I² = 63%, likely due to differences in women's management. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004735-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004735-sec-0044"></div> <section id="CD004735-sec-0045"> <h3 class="title" id="CD004735-sec-0045">Description of the condition</h3> <p>Preterm prelabour rupture of the membranes (PPROM) occurs when there is rupture of the membranes prior to term and prior to the onset of labour. PPROM complicates pregnancy for 1% to 2% of all women and is associated with 30% to 40% of preterm births (less than 37 weeks) (<a href="./references#CD004735-bbs2-0030" title="AriasF , TomichP . Etiology and outcome of low birthweight and preterm infants. Obstetrics &amp; Gynecology1982;338:663‐70. ">Arias 1982</a>; <a href="./references#CD004735-bbs2-0043" title="LeeT , SilverH . Etiology and epidemiology of preterm premature rupture of the membranes. Clinical Perinatology2001;28:721‐34. ">Lee 2001</a>; <a href="./references#CD004735-bbs2-0046" title="MercerBM , GoldenbergRL , MeisPJ , MoawadAH , ShellhaasC , DasA , et al. The preterm prediction study: prediction of preterm premature rupture of the membranes through clinical findings and ancillary testing. American Journal of Obstetrics and Gynecology2000;183:738‐45. ">Mercer 2000</a>; <a href="./references#CD004735-bbs2-0048" title="MercerBM . Preterm premature rupture of the membranes: current approaches to evaluation and management. Obstetrics and Gynecology Clinics of North America2005;32:411‐28. ">Mercer 2005</a>). </p> </section> <section id="CD004735-sec-0046"> <h3 class="title" id="CD004735-sec-0046">Description of the intervention</h3> <p>The purpose of this review is to determine the optimal management for women and their babies with pregnancies complicated by PPROM. This could either be planned delivery soon after rupture of the membranes or expectant management. Planned early birth involves the birth of the baby near to the time of rupture of the membranes and may be by induction of labour or caesarean section. Expectant management involves observation of the mother and baby and awaiting the spontaneous onset of labour in the absence of any complications that may necessitate delivery. Women with PPROM who are managed expectantly may then have the delivery of their baby planned for term if labour has not ensued. </p> </section> <section id="CD004735-sec-0047"> <h3 class="title" id="CD004735-sec-0047">How the intervention might work</h3> <p>The management of PPROM is dependent upon the gestation at which rupture of the membranes occurs. The health benefits for the fetus in continuing a pregnancy after PPROM may be considerable, particularly in the late second and early third trimesters. However, there is currently no consensus as to the optimal management of PPROM in women in whom the fetus is relatively mature, at gestations near to term such as in the late second trimester and third trimester of pregnancy. The aim of care for women with PPROM is to maximise the benefits of further fetal maturity while avoiding the potential harms of remaining in utero. </p> <p>There are treatments such as antibiotics and antenatal corticosteroids that can reduce associated complications for the mother and baby in pregnancies complicated by PPROM. The use of antibiotics in PPROM significantly improves neonatal and maternal morbidity including prolongation of pregnancy, reduction in neonatal infection, reduced need for oxygen therapy and less risk of abnormal cerebral ultrasound (<a href="./references#CD004735-bbs2-0041" title="KenyonS , TaylorDJ , Tarnow‐MordiW . Broad spectrum antibiotics for preterm, prelabour rupture of the fetal membranes: the ORACLE I randomised trial. Lancet2001;357:979‐88. ">Kenyon 2001</a>; <a href="./references#CD004735-bbs2-0042" title="KenyonS , BoulvainM , NeilsonJ . Antibiotics for preterm premature rupture of the membranes. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD001058] ">Kenyon 2003</a>). In addition, antenatal corticosteroids have been shown to reduce the risk of neonatal respiratory distress, intraventricular haemorrhage (bleeding within the ventricles of the baby's brain) and neonatal death in the preterm neonate (<a href="./references#CD004735-bbs2-0052" title="RobertsD , DalzielS . Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD004454.pub2] ">Roberts 2006</a>). These beneficial effects of corticosteroids also apply to women with PPROM (<a href="./references#CD004735-bbs2-0037" title="HardingJE , PangJM , KnightDB , LigginsGC . Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. American Journal of Obstetrics and Gynecology2001;184:131‐9. ">Harding 2001</a>). </p> </section> <section id="CD004735-sec-0048"> <h3 class="title" id="CD004735-sec-0048">Why it is important to do this review</h3> <p>There are recognised maternal and fetal risks associated with PPROM. These complications decrease the nearer to term that PPROM occurs. The recognised complications include ascending infection, cord prolapse (prolapsing of the umbilical cord through the cervix), intrapartum fetal distress and abruption (premature detachment of the placenta from the uterine wall) (<a href="./references#CD004735-bbs2-0035" title="GonenR , HannahME , MilliganJE . Does prolonged preterm premature rupture of the membranes predispose to abruptio placentae?. Obstetrics &amp; Gynecology1989;74(3):347‐50. ">Gonen 1989</a>; <a href="./references#CD004735-bbs2-0045" title="MajorCA , deVecianaM , LewisDF , MorganMA . Preterm premature rupture of the membranes and abruptio placentae: is there an association between these pregnancy complications?. American Journal of Obstetrics and Gynecology1995;172(2):672‐6. ">Major 1995</a>; <a href="./references#CD004735-bbs2-0047" title="MercerBM . Preterm premature rupture of the membranes. Obstetrics &amp; Gynecology2003;101(1):178‐93. ">Mercer 2003</a>). It may be that managing PPROM expectantly by awaiting the spontaneous onset of labour increases the risk to the fetus of these complications. In particular prolonged exposure to intrauterine infection is of major concern for the neonate. In fact it has been demonstrated that neonatal sepsis is twice as common in the setting of PPROM compared with preterm birth after preterm labour with intact membranes (<a href="./references#CD004735-bbs2-0054" title="SeoK , McGregorJA , FrenchJI . Preterm birth is associated with increased risk of maternal and neonatal infection. Obstetrics &amp; Gynecology1992;79:75‐80. ">Seo 1992</a>). </p> <p>There are potential risks associated with planned early delivery in pregnancies complicated by PPROM between 30 and 37 weeks' gestation. In particular the attendant risks of iatrogenic prematurity associated with birth before term but greater than 30 weeks' gestation are significant. These complications may include respiratory distress (<a href="./references#CD004735-bbs2-0040" title="JonesSC , BrostBC , BrehmWT . Should intravenous tocolysis be considered beyond 34 weeks' gestation?. American Journal of Obstetrics and Gynecology2000;183(2):356‐60. ">Jones 2000</a>; <a href="./references#CD004735-bbs2-0044" title="LewisDF , FutayyehS , TowersCV , AsratT , EdwardsMS , BrooksGG . Preterm delivery from 34‐37 weeks gestation: is respiratory distress syndrome a problem?. American Journal of Obstetrics and Gynecology1996;174(2):525‐8. ">Lewis 1996</a>), sepsis, necrotising enterocolitis (injury to the bowel of newborn babies), intraventricular haemorrhage, prolonged stays in the neonatal nursery, difficulty with thermoregulation and difficulty with breastfeeding (<a href="./references#CD004735-bbs2-0033" title="EngleWA , KominiarekMA . Late preterm infants, early term infants, and timing of elective deliveries. Clinics in Perinatology2008;35:325‐41. ">Engle 2008</a>; <a href="./references#CD004735-bbs2-0053" title="RobertsonPA , SnidermanSH , LarosRKJr , CowanR , HeilbronD , GoldenbergRL , et al. Neonatal morbidity according to gestational age and birth weight from five tertiary care centers in the United States, 1983 through 1986. American Journal of Obstetrics and Gynecology1992;166:1629‐45. ">Robertson 1992</a>). These complications are less common when delivery occurs after 32 weeks' gestation (<a href="./references#CD004735-bbs2-0047" title="MercerBM . Preterm premature rupture of the membranes. Obstetrics &amp; Gynecology2003;101(1):178‐93. ">Mercer 2003</a>). A number of retrospective studies have similarly found a decrease in neonatal morbidity associated with birth at 34 weeks' gestation (<a href="./references#CD004735-bbs2-0044" title="LewisDF , FutayyehS , TowersCV , AsratT , EdwardsMS , BrooksGG . Preterm delivery from 34‐37 weeks gestation: is respiratory distress syndrome a problem?. American Journal of Obstetrics and Gynecology1996;174(2):525‐8. ">Lewis 1996</a>; <a href="./references#CD004735-bbs2-0050" title="NeerhofMG , CravelloC , HaneyEI , SilverRK . Timing of labor induction after premature rupture of membranes between 32 and 36 weeks gestation. American Journal of Obstetrics and Gynecology1999;180(2):349‐52. ">Neerhof 1999</a>). The incidence of respiratory distress syndrome, hyperbilirubinaemia (high bilirubin within in the babies' blood which results in a yellow discolouration of the neonates' skin referred to as jaundice) and duration of stay in the neonatal nursery was significantly reduced in infants born after 34 weeks' gestation compared with those born before 34 weeks (<a href="./references#CD004735-bbs2-0044" title="LewisDF , FutayyehS , TowersCV , AsratT , EdwardsMS , BrooksGG . Preterm delivery from 34‐37 weeks gestation: is respiratory distress syndrome a problem?. American Journal of Obstetrics and Gynecology1996;174(2):525‐8. ">Lewis 1996</a>; <a href="./references#CD004735-bbs2-0050" title="NeerhofMG , CravelloC , HaneyEI , SilverRK . Timing of labor induction after premature rupture of membranes between 32 and 36 weeks gestation. American Journal of Obstetrics and Gynecology1999;180(2):349‐52. ">Neerhof 1999</a>). Infants born beyond 34 weeks' gestation do have better outcomes than those born prior to 34 weeks, however those babies born between 34 and 37 weeks' gestation are still physiologically immature and as such do have significantly increased morbidity and mortality as compared with those infants born at term (<a href="./references#CD004735-bbs2-0032" title="EngleWA , TomashekKM , WallmanC . Late preterm infants: a population at risk. Pediatrics2007;120:1390‐401. ">Engle 2007</a>; <a href="./references#CD004735-bbs2-0033" title="EngleWA , KominiarekMA . Late preterm infants, early term infants, and timing of elective deliveries. Clinics in Perinatology2008;35:325‐41. ">Engle 2008</a>). </p> <p>The previous version of this review (<a href="./references#CD004735-bbs2-0057" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735.pub3] ">Buchanan 2010</a>), which included seven trials and 690 women, found there was insufficient evidence available at that time to guide clinical practice and that all included trials had methodological weaknesses. </p> <p>There is consensus on the management of term pregnancies with PROM (prelabour rupture of the membranes) (<a href="./references#CD004735-bbs2-0049" title="MiddletonP , ShepherdE , FlenadyV , McBainRD , CrowtherCA . Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD005302.pub3] ">Middleton 2017</a>). This Cochrane review found that fewer women in the planned compared with the expectant management groups had chorioamnionitis (inflammation of the fetal membranes) and/or endometritis (a postpartum infection of the lining of the womb) (average risk ratio (RR) 0.49, 95% confidence interval (CI) 0.33 to 0.72, eight trials, 6864 women). Additionally, early birth appeared to reduce the likelihood of definite or probable early‐onset neonatal sepsis (RR 0.73, 95% CI 0.58 to 0.92, sixteen trials, 7314 infants). There was no clear difference in the mode of birth between the groups. </p> <p>It is evident that there is an increased incidence of chorioamnionitis associated with expectant management in women with PROM (<a href="./references#CD004735-bbs2-0036" title="HannahME , OhlssonA , FarineD , HewsonSA , HodnettED , MyhrTL , et al. Induction of labor compared with expectant management for prelabor rupture of the membranes at term. New England Journal of Medicine1996;334(16):1005‐10. ">Hannah 1996</a>). Histological evidence of chorioamnionitis is present in up to 50% of women who deliver preterm and is often not associated with clinical symptoms or signs. Chorioamnionitis is a known significant risk factor for the development of both cystic periventricular leukomalacia (cystic changes around the ventricles of the babies brain) and cerebral palsy (<a href="./references#CD004735-bbs2-0034" title="GaudetL , SmithGN . Cerebral palsy and chorioamnionitis: the inflammatory cytokine link. Obstetrical and Gynecological Survey2001;56(7):433‐6. ">Gaudet 2001</a>; <a href="./references#CD004735-bbs2-0056" title="WuYW , ColfordJM . Chorioamnionitis as a risk factor for cerebral palsy: a meta‐analysis. JAMA2000;284(11):1417‐24. ">Wu 2000</a>). Therefore, the question remains as to whether there is an increased chance of an adverse neurological outcome in those infants whose mothers are managed expectantly with PPROM by increasing their duration of exposure to often subclinical chorioamnionitis. </p> <p>The objective of this review is to assess and further define the optimal management for women with PPROM prior to 37 weeks' gestation. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004735-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004735-sec-0049"></div> <p>To assess the effect of planned early birth versus expectant management for women with preterm prelabour rupture of the membranes between 24 and 37 weeks' gestation for fetal, infant and maternal well being. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004735-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004735-sec-0050"></div> <section id="CD004735-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004735-sec-0052"> <h4 class="title">Types of studies</h4> <p>We considered for inclusion all identified randomised controlled trials (RCTs) comparing planned early birth versus expectant management for women with preterm prelabour rupture of the membranes (PPROM) prior to 37 weeks' gestation. We did not consider quasi‐randomised studies for inclusion in the review. We also assessed for inclusion studies that were presented in abstract form only. </p> <p>In studies in which gestational ages overlapped the less‐than‐37‐week gestation inclusion criteria, we attempted to extract gestational age‐specific data from the studies. We also attempted to contact researchers to provide further information. </p> </section> <section id="CD004735-sec-0053"> <h4 class="title">Types of participants</h4> <p>Women with PPROM before 37 weeks' gestation with no specific maternal or fetal contraindications to expectant management. </p> </section> <section id="CD004735-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Planned early birth compared with expectant management.</p> <p>Planned early birth is planned birth soon after PPROM. The mode of birth may either be via induction of labour by any means and a vaginal birth, or by caesarean section. </p> <p>Expectant management involves planning to wait for birth until the baby is at term.</p> </section> <section id="CD004735-sec-0055"> <h4 class="title">Types of outcome measures</h4> <section id="CD004735-sec-0056"> <h5 class="title">Primary outcomes</h5> <p>Neonatal infection/sepsis:</p> <p> <ul id="CD004735-list-0001"> <li> <p>proven neonatal infection with positive blood culture within 48 hours of birth;</p> </li> <li> <p>proven neonatal infection with positive blood culture 48 hours or more after birth.</p> </li> </ul> </p> <p>Respiratory distress syndrome<br/> Caesarean section </p> </section> <section id="CD004735-sec-0057"> <h5 class="title">Secondary outcomes</h5> <section id="CD004735-sec-0058"> <h6 class="title">Fetal/perinatal outcomes</h6> <p>Perinatal death<br/> Intrauterine death<br/> Cord prolapse<br/> Gestational age at birth </p> </section> <section id="CD004735-sec-0059"> <h6 class="title">Neonatal outcomes</h6> <p>Neonatal death<br/> Suspected neonatal infection<br/> Treatment with antibiotics<br/> Treatment with surfactant<br/> Need for ventilation<br/> Days of neonatal ventilation<br/> Duration of oxygen therapy<br/> Oxygen therapy at 36 weeks' postmenstrual age<br/> Cord arterial pH<br/> Birthweight<br/> Apgar score less than 7 at five minutes<br/> Abnormality on cerebral ultrasound: </p> <p> <ul id="CD004735-list-0002"> <li> <p>cystic periventricular leukomalacia;</p> </li> <li> <p>cerebroventricular haemorrhage (including grade of intraventricular haemorrhage).</p> </li> </ul> </p> <p>Necrotising enterocolitis<br/> Admission to neonatal intensive care unit<br/> Admission to neonatal intensive care unit after 24 hours<br/> Length of stay in neonatal intensive care unit<br/> Days from birth to discharge home from hospital<br/> Disability at time of childhood follow‐up </p> </section> <section id="CD004735-sec-0060"> <h6 class="title">Maternal outcomes</h6> <p>Chorioamnionitis<br/> Endometritis<br/> Postpartum fever<br/> Placental abruption<br/> Induction of labour<br/> Mode of induction of labour<br/> Use of epidural anaesthesia<br/> Vaginal birth<br/> Operative vaginal birth<br/> Caesarean section for fetal distress<br/> Duration of hospitalisation: </p> <p> <ul id="CD004735-list-0003"> <li> <p>days of antenatal hospitalisation;</p> </li> <li> <p>days of postnatal hospitalisation.</p> </li> </ul> </p> <p>Maternal satisfaction:</p> <p> <ul id="CD004735-list-0004"> <li> <p>views of care;</p> </li> <li> <p>preferences of care;</p> </li> <li> <p>presence of postnatal depression.</p> </li> </ul> </p> <p>Breastfeeding:</p> <p> <ul id="CD004735-list-0005"> <li> <p>whether breastfeeding established;</p> </li> <li> <p>time after birth breastfeeding established.</p> </li> </ul> </p> </section> </section> </section> </section> <section id="CD004735-sec-0061"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD004735-sec-0062"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (30 September 2016). </p> <p>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For full search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD004735-list-0006"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Two people screen search results and review the full text of all relevant trial reports identified through the searching activities described above. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD004735-bbs1-0001" title="">Included studies</a>; <a href="./references#CD004735-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD004735-bbs1-0003" title="">Ongoing studies</a>). </p> <p>For the 2010 update (<a href="./references#CD004735-bbs2-0057" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735.pub3] ">Buchanan 2010</a>), we carried out additional author searching. See <a href="https://archie.cochrane.org/sections/documents/view?version=z1509141407172055086868654089064%26format=REVMAN_GRAPHS#APP-01" target="_blank">Appendix 1</a> for details. </p> </section> <section id="CD004735-sec-0063"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of trials and other review articles. We contacted researchers to provide further information as required. We did not apply any language or date restrictions. </p> </section> </section> <section id="CD004735-sec-0064"> <h3 class="title" id="CD004735-sec-0064">Data collection and analysis</h3> <p>For the methods used when assessing the trials identified in the previous version of this review, see <a href="./references#CD004735-bbs2-0057" title="BuchananSL , CrowtherCA , LevettKM , MiddletonP , MorrisJ . Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane Database of Systematic Reviews2010, Issue 3. [DOI: 10.1002/14651858.CD004735.pub3] ">Buchanan 2010</a>. </p> <p>For this update, we used the following methods for assessing the 11 additional reports that were identified as a result of the updated search. </p> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD004735-sec-0065"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted a third review author. </p> </section> <section id="CD004735-sec-0066"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data based on Cochrane Pregnancy and Childbirth recommendations. For eligible studies, two review authors (DB and JM) extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted the third review author (KL). One author (DB) entered data into Review Manager 5 (RevMan) software (<a href="./references#CD004735-bbs2-0051" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and two others checked for accuracy (JM, KL). </p> <p>David P van der Ham was Chief Investigator and first author of the PPROMEXIL trials and so JM and DB were responsible for data extraction and assessment of all trial reports relating to this study. Jonathan Morris was the Chief Investigator and first author for the NHMRC‐ (National Health and Medical Research Council) funded PPROMT trial and so data was assessed and extracted independently by PM. </p> <p>When information regarding any of the above was unclear, we contacted authors of the original reports to provide further details. </p> </section> <section id="CD004735-sec-0067"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (DB and KL) independently assessed risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD004735-bbs2-0039" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We resolved any disagreement by discussion or by involving a third assessor. </p> <section id="CD004735-sec-0068"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We have assessed the method as:</p> <p> <ul id="CD004735-list-0007"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0069"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We have assessed the methods as:</p> <p> <ul id="CD004735-list-0008"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0070"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We have assessed the methods as:</p> <p> <ul id="CD004735-list-0009"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0071"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We have assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD004735-list-0010"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0072"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses that we undertook. </p> <p>We have assessed methods as:</p> <p> <ul id="CD004735-list-0011"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0073"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We have assessed the methods as:</p> <p> <ul id="CD004735-list-0012"> <li> <p>low risk of bias (where it was clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review were reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes were reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD004735-sec-0074"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD004735-sec-0075"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the Handbook for Systematic Reviews of Interventions (<a href="./references#CD004735-bbs2-0039" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ see <a href="http://archie.cochrane.org/sections/documents/view?version=z1212181516253162684622876719716%26format=REVMAN_GRAPHS#SENSITIVITY_ANALYSIS" target="_blank">Sensitivity analysis</a>. </p> </section> <section id="CD004735-sec-0076"> <h5 class="title">Assessment of the quality of evidence using the GRADE approach</h5> <p>For this update we assessed the quality of the evidence using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the following outcomes for the main comparisons. </p> <p> <ul id="CD004735-list-0013"> <li> <p>Neonatal infection/sepsis</p> </li> <li> <p>Neonatal respiratory distress syndrome</p> </li> <li> <p>Need for ventilation</p> </li> <li> <p>Admission to neonatal intensive care</p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Chorioamnionitis</p> </li> <li> <p>Length of hospital stay (maternal)</p> </li> </ul> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEproGDT</a> (GRADEpro Guideline Development Tool) to import data from RevMan 5.3 (<a href="./references#CD004735-bbs2-0051" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) to create 'Summary of findings' tables. We produced a summary of the intervention effect and a measure of quality for each of the above outcomes using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD004735-sec-0077"> <h4 class="title">Measures of treatment effect</h4> <section id="CD004735-sec-0078"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio (RR) with 95% confidence intervals (CI). </p> </section> <section id="CD004735-sec-0079"> <h5 class="title">Continuous data</h5> <p>We used the mean difference (MD) if outcomes were measured in the same way between trials. In future updates if appropriate, we will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD004735-sec-0080"> <h4 class="title">Unit of analysis issues</h4> <p>We considered trials including twin pregnancies for inclusion in the review. For trials that included twin pregnancies, for fetal outcomes the denominator used for analysis was the number of pregnancies. However, for neonatal outcomes the denominator used for analysis was the number of individual babies randomised. </p> <section id="CD004735-sec-0081"> <h5 class="title">Cluster‐randomised trials</h5> <p>Cluster‐randomised trials were not eligible for inclusion in this review.</p> </section> <section id="CD004735-sec-0082"> <h5 class="title">Cross‐over trials</h5> <p>Cross‐over trials were not eligible for inclusion in this review.</p> </section> </section> <section id="CD004735-sec-0083"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, that is, we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD004735-sec-0084"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² (<a href="./references#CD004735-bbs2-0038" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327:557‐60. ">Higgins 2003</a>) and Chi² statistics. We regarded heterogeneity as substantial if I² was greater than 30% and either Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 50%), we planned to explore it by pre‐specified subgroup analysis (<a href="./references#CD004735-bbs2-0031" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD004735-sec-0085"> <h4 class="title">Assessment of reporting biases</h4> <p>In this update, if there were 10 or more studies in the meta‐analysis, we investigated reporting biases (such as publication bias) using funnel plots. We assessed funnel plot asymmetry visually. If asymmetry was suggested by a visual assessment, we planned to perform an exploratory analyses to investigate it (<a href="./references#CD004735-bbs2-0055" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). </p> </section> <section id="CD004735-sec-0086"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the RevMan software (<a href="./references#CD004735-bbs2-0051" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: that is, where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary if an average treatment effect across trials was considered clinically meaningful. We treated the random‐effects summary as the average range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. If we used random‐effects analyses, we presented the results as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I² tests. </p> </section> <section id="CD004735-sec-0087"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If we identified substantial heterogeneity, we investigated it using subgroup analyses and sensitivity analyses. We considered whether an overall summary was meaningful, and if it was, we used random‐effects analysis to produce it. </p> <p>We carried out the following subgroup analyses.</p> <p> <ul id="CD004735-list-0014"> <li> <p>Corticosteroid usage versus no corticosteroid usage</p> </li> <li> <p>Gestational age at randomisation with stratification into:</p> <ul id="CD004735-list-0015"> <li> <p>less than 30 weeks' gestation</p> </li> <li> <p>30 to 33 plus 6 weeks' gestation</p> </li> <li> <p>34 to 37 weeks' gestation</p> </li> </ul> </li> <li> <p>Antibiotic usage versus no antibiotic usage</p> </li> <li> <p>Time from randomisation to early birth: less than 24 hours versus greater than 24 hours </p> </li> </ul> </p> <p>We used the following outcomes in subgroup analyses.</p> <section id="CD004735-sec-0088"> <h5 class="title">Fetal/neonatal outcomes</h5> <p>Neonatal infection<br/> Neonatal infection confirmed with positive blood culture<br/> Respiratory distress syndrome </p> </section> <section id="CD004735-sec-0089"> <h5 class="title">Maternal outcomes</h5> <p>Caesarean section<br/> Chorioamnionitis<br/> Endometritis </p> <p>We assessed subgroup differences by interaction tests available within RevMan (<a href="./references#CD004735-bbs2-0051" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value. </p> </section> </section> <section id="CD004735-sec-0090"> <h4 class="title">Sensitivity analysis</h4> <p>We included all eligible trials in the initial analysis and planned to carry out sensitivity analyses to evaluate the effect of trial quality. We also planned to perform a sensitivity analysis based on the randomisation process, assessing the presence of blinding of assessors to the primary outcome, assessing the quality of treatment allocation and assessing the presence of losses to follow‐up<b>.</b> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004735-sec-0091" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004735-sec-0091"></div> <section id="CD004735-sec-0092"> <h3 class="title">Description of studies</h3> <p>Refer to the <a href="./references#CD004735-sec-0161" title="">Characteristics of included studies</a> and <a href="./references#CD004735-sec-0162" title="">Characteristics of excluded studies</a> tables for further detailed information on individual studies. </p> <section id="CD004735-sec-0093"> <h4 class="title">Results of the search</h4> <p>The search of the Cochrane Pregnancy and Childbirth's Trials Register retrieved 14 additional reports for consideration in this updated review, which contributed four additional studies to the review. Five of the reports were based on one study (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>), six on another (<a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>), four on the third (<a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) and one on the fourth (<a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>). We moved one study from 'excluded studies' in the first review to 'included studies' (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>) in this update as the authors felt the study fitted the inclusion criteria after translation into English. We moved another study from 'ongoing' to 'excluded' as the trial was terminated prematurely due to poor recruitment (<a href="./references#CD004735-bbs2-0021" title="LacazeN . Safety and efficacy study of intentional delivery in women with preterm and prelabour rupture of the membranes (ongoing trial). www.clinicaltrials.gov (accessed 21 March 2006)2006. ">Lacaze 2006</a>). One study remained ongoing as we were unable to ascertain the current status (<a href="./references#CD004735-bbs2-0029" title="PasquierJC , BujoldE , MellieG . Preterm premature rupture of membranes: is there an optimal gestational age for delivery?. Obstetrics &amp; Gynecology2005;105(6):1484‐5. PasquierJC , ClarisO , RabilloudM , PicaudJC , MoretS , EcochardR , et al. Feeling and motivation of women to participate in a randomized control trial in perinatality. American Journal of Obstetrics and Gynecology2006;195(6 Suppl 1):S69. ">Pasquier 2006</a>). See <a href="#CD004735-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD004735-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD004735-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> </section> <section id="CD004735-sec-0094"> <h4 class="title">Included studies</h4> <p>We have included 12 randomised controlled trials in this review, which comprise 3617 women and 3628 babies (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>). One study was performed in Albania (<a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>), one in Mexico (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>), two in the Netherlands (<a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>), and one, though based in Australia, included a total of 11 countries: Australia, Argentina, Brazil, Egypt, New Zealand, Norway, Poland, Romania, South Africa, UK and Uruguay (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>). The other seven studies were performed in the USA. All but one of the included studies were reported in English, but we were able to translate the Mexican study (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>) from Spanish to English. Five studies recruited women from multiple sites (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>), while the remainder recruited from a single centre only (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>). The studies were performed between 1977 and 2016. As <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> was a published abstract only, this study provided limited information for this review and as a result has been excluded from most of the following discussion about participants, interventions and outcomes. Outcomes were included in the analysis only. </p> <p>A summary of the trials is provided (<a href="#CD004735-tbl-0002">Table 1</a>). </p> <div class="table" id="CD004735-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of trials assessing early birth with expectant management in women with PPROM</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gestational age for inclusion (weeks)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Co‐interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fetal lung maturity tested</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129</p> <p>(131 babies)</p> <p>61 ED</p> <p>(62 babies)</p> <p>68 EM</p> <p>(69 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0016"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> <p>30 ED</p> <p>28 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0017"> <li> <p>ED group given fetal lung maturity protocol of 6 doses of 250 mg of intravenous aminophylline every 8 hours </p> </li> <li> <p>EM group managed with the same lung maturity protocol repeated weekly</p> </li> <li> <p>No prophylactic antibiotics</p> </li> <li> <p>Tocolysis if contracting</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, if positive <b>excluded</b> from randomisation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> <p>80 ED</p> <p>80 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0018"> <li> <p>Corticosteroids to ED group</p> </li> <li> <p>Tocolysis to ED group if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: if L/S mature <b>excluded</b> from randomisation and delivered </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> <p>38 ED</p> <p>35 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0019"> <li> <p>Corticosteroids to ED group</p> </li> <li> <p>Tocolysis to ED group if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: if mature L/S <b>excluded</b> from randomisation and delivered </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>307</p> <p>157 ED</p> <p>150 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0020"> <li> <p>Not mentioned</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93</p> <p>46 ED</p> <p>47 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0021"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: <b>included</b> if mature L/S </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1835</p> <p>923 ED</p> <p>912 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0022"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Corticosteroids according to local protocol</p> </li> <li> <p>Tocolysis according to local protocol</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> <p>57 ED</p> <p>63 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0023"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>Prophylactic antibiotics for all women</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> <p>22 ED and steroids</p> <p>22 ED and no steroids</p> <p>24 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0024"> <li> <p>Corticosteroids only to 1 of ED groups</p> </li> <li> <p>Tocolysis to ED groups if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> <p>26 to ED</p> <p>21 to EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 to 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0025"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: <b>included</b> if mature L/S </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>532</p> <p>(538 babies)</p> <p>266 ED</p> <p>(268 babies)</p> <p>266 EM</p> <p>(270 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0026"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Tocolysis dependent on local protocol</p> </li> <li> <p>Corticosteroids given in PPROM &lt; 34 weeks' gestational age</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>195</p> <p>(198 babies)</p> <p>100 ED</p> <p>(100 babies)</p> <p>95 EM</p> <p>(98 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0027"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Tocolysis dependent on local protocol</p> </li> <li> <p>Corticosteroids given in PPROM &lt; 34 weeks' gestational age</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>ED: early delivery<br/> EM: expectant management<br/> L/S: lecithin‐sphingomyelin </p> </div> </div> <section id="CD004735-sec-0095"> <h5 class="title">Participants</h5> <p>The studies included women with pregnancies complicated by preterm prelabour rupture of the membranes (PPROM) of differing gestational ages. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>, <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>, <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> and <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a> included women with PPROM between 28 and 34 weeks' gestation, while <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> included women from 25 to 36 weeks' gestation. <a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a> included women with PPROM at 30 to 34 weeks' gestation. <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> included women from 32 to 36 weeks' gestation, while <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>, <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> included women from 34 weeks' gestation to 36 weeks' plus six days' gestation. Three trials (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) included twin pregnancies for a total of three pairs of twins randomised to early birth and eight pairs randomised to expectant management. One study (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>), although inclusion criteria specified singleton pregnancies only, reported outcomes for two sets of twins in each group in the analysis. </p> <p>Importantly, the entry criteria also differed between the studies. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>, <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>, <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>, <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> and <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> required amniotic fluid sampling to assess fetal pulmonary maturity prior to study entry. <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> and <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> used a mature lecithin‐sphingomyelin (L/S) as an exclusion criteria and then treated the early birth group with corticosteroids, while in contrast <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> and <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> used a mature L/S as an inclusion criteria and did not use antenatal corticosteroids. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> excluded women with 'positive' fetal lung maturity tests based on "tap*, clements* and 650 nm spectrophotometry" (*we were unsure of the definition of these tests, which may have been an error in translation) and used a different fetal lung maturity protocol of intravenous aminophylline for each arm of the trial. They also required an amniotic fluid index of greater than 5 cm for trial inclusion. <a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>, <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>, <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>, <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> did not require documented pulmonary maturity prior to study entry. Exclusion criteria included active labour, chorioamnionitis or non‐reassuring fetal status as assessed at the time of randomisation in all the studies. <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> included an additional broadly defined exclusion as being any other contraindications to continuing the pregnancy, while <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> more specifically included additional exclusion criteria as being: monochorionic multiple pregnancy; major fetal anomalies; haemolysis; elevated liver enzymes and low platelets (HELLP) syndrome; and severe pre‐eclampsia (see <a href="#CD004735-tbl-0002">Table 1</a>). </p> <p>All of the studies defined determination of gestational age for inclusion by menstrual history or early ultrasound examination to give the most accurate clinical estimate. In the absence of an accurate clinical estimate, seven of the studies used ultrasound at the time of presentation to hospital to date the pregnancy (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>). </p> <p>All of the trials defined ruptured membranes by clinical assessment with a sterile speculum examination and visualising amniotic fluid passing through the cervical os and pooling in the posterior fornix of the vagina. Six of the trials (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) also confirmed the presence of PPROM with a Nitrazine test to demonstrate an alkaline pH and or ferning of a specimen of vaginal fluid on microscopy. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> used 'cristallography' or the 'flame test' as an additional diagnosis. </p> <p>Six of the included trials (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) did not allow digital cervical examinations to be performed in the absence of labour. </p> </section> <section id="CD004735-sec-0096"> <h5 class="title">Intervention</h5> <p>The intervention assessed by these studies was the effect of early birth on maternal and fetal well being. The timing of intervention for early birth differed between the studies. The mean latency from PROM to birth in four studies (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) indicated that birth was planned as soon as practicable from randomisation and less than 24 hours, although this was not explicitly stated in all the trials. One study (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>) did not indicate when birth was intended but results indicated a median latency of three days. <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a> planned for early birth between 24 and 48 hours after initial rupture of membranes and 24 hours after initiation of steroid therapy, while <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> defined planned early birth as 48 hours after treatment with corticosteroids. <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> had an even longer delay in the early birth group and planned for early birth 48 to 72 hours after PPROM and initiation of steroid treatment. <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> defined timing of birth as birth scheduled as close to randomisation as possible and preferably within 24 hours. In both <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> women were randomised if not spontaneously delivered within 24 hours after initial rupture of membranes and women randomised to early birth were induced within 24 hours after randomisation. </p> <p>The only study with a control arm of early birth for PPROM was <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>. As a result, for the discussion and analysis, we flipped the definition and results for the 'treatment' group and the 'control' group in this study to be consistent with the rest of the studies, which all defined the control arm as being expectant management. The intention of expectant management was defined in the majority of studies as waiting until spontaneous labour or until there was medical indication to facilitate birth, such as infection or fetal distress. The exceptions were <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>, <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> and <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>, which did not specify the intent of expectant management, although <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> did indicate in an outcomes table that the reasons for delivery in the expectant management group were onset of labour, infection, oligohydramnios and fetal distress. <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>, <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>, <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> allowed women to be discharged home at the discretion of the attending physician or according to local protocol, while the remainder of the studies required the women in the trial to be hospitalised until birth. </p> <p>The co‐interventions also differed between the included studies. <a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>, <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>, <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a> and <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> did not treat the women with corticosteroids or tocolysis. <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> and <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> treated women in the early birth groups with corticosteroids and tocolysis as required. <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a> randomised women to steroids or no steroid therapy in the early birth group. These women in the early birth group were also treated with tocolytics. <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> used tocolytics, antibiotics and corticosteroids according to local protocol, whereas <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> only used tocolytics and antibiotics according to local protocol, but gave corticosteroids to women with PPROM less than 34 weeks' gestation. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> used tocolytics as well as a fetal lung maturity protocol of intravenous aminophylline in the early birth arm, which was repeated weekly in the women randomised to expectant management. Antibiotics were not used unless there were signs of chorioamnionitis, in which case birth was indicated. <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a> was the only trial in which prophylactic antibiotics were used for all women. In this trial all women were treated with ampicillin. </p> </section> <section id="CD004735-sec-0097"> <h5 class="title">Outcomes</h5> <p>Neonatal infection was variably defined in the studies. <a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>, <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> and <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> did not document their criteria required for documenting neonatal infection while <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>, <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>, <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>, <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>, <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>, <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> required a positive culture of blood, cerebrospinal fluid or urine in addition to clinical features of sepsis for diagnosis. </p> <p>Chorioamnionitis was defined in all of the studies as maternal temperature associated with uterine tenderness, maternal or fetal tachycardia, or both, and/or foul smelling amniotic fluid in the absence of any other cause of identifiable infection. None of the studies confirmed the presence of clinical chorioamnionitis pathologically with a histological examination of the placenta and fetal membranes. <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> additionally included in their diagnosis a leucocyte count of 15,000 in maternal blood at the start of the study or a 50% increase from the baseline reading. </p> </section> </section> <section id="CD004735-sec-0098"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 studies from the review (see <a href="./references#CD004735-sec-0162" title="">Characteristics of excluded studies</a>). <a href="./references#CD004735-bbs2-0017" title="FayezJA , HasanAA , JonasHS , MillerGL . Management of premature rupture of the membranes. Obstetrics &amp; Gynecology1978; Vol. 52:17‐21. ">Fayez 1978</a> used a quasi‐randomisation schema in which women were randomised to either early birth or expectant management based on odd or even hospital record numbers. We also excluded <a href="./references#CD004735-bbs2-0026" title="ParsonsMT , SobelD , CummiskeyK , RoitmanJ , GallSA . Early delivery vs expectant management in patients with preterm rupture of membranes at 32‐36 weeks gestation. Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 Feb 1‐4; New Orleans, Louisiana, USA. 1989:391. ">Parsons 1989</a> and <a href="./references#CD004735-bbs2-0013" title="BergstromS . A prospective study on the perinatal outcome in Mozambican pregnant women with preterm rupture of membranes using two different methods of clinical management. Gynecologic &amp; Obstetric Investigation1991;32:217‐9. ">Bergstrom 1991</a> as these were prospective but not randomised trials. </p> <p>We excluded six trials (<a href="./references#CD004735-bbs2-0014" title="CararachV , SentisJ , BotetF , CostaJ , ManauD , ArimanyMC . Cervical prostaglandin E2 compared with expectant management or systematic induction in PROM with bad cervical conditions: I‐maternal results. Proceedings of 14th European Congress of Perinatal Medicine; 1994 June 5‐8; Helsinki, Finland. 1994:405. ">Cararach 1994</a>; <a href="./references#CD004735-bbs2-0018" title="GloebDJ , O'SullivanMJ , BeydounSN . Relationship of the interval between spontaneous premature rupture of the membranes and inducibility of labor. Proceedings of 9th Annual Meeting of the Society of Perinatal Obstetricians; 1989 February 1‐4; New Orleans, Louisiana, USA. 1989:493. ">Gloeb 1989</a>; <a href="./references#CD004735-bbs2-0019" title="Griffith‐JonesMD , TyrrellSN , TuffnellDJ . A prospective trial comparing intravenous oxytocin with vaginal prostaglandin E2 tablets for labour induction in cases of spontaneous rupture of the membranes. Obstetrics and Gynaecology Today1990;1(4):104‐5. ">Griffith‐Jones 1990</a>; <a href="./references#CD004735-bbs2-0022" title="LadforsL , MattssonLA , ErikssonM , FallO . A randomised trial of two expectant managements of prelabour rupture of the membranes at 34 to 42 weeks. British Journal of Obstetrics and Gynaecology1996;103:755‐62. LadforsL , MattssonLA , ErikssonM , FallO . A randomized prospective trial of two expectant managements of pre‐labor rupture of the membranes (PROM) at 34‐42 weeks. American Journal of Obstetrics and Gynecology1994;170:344. LadforsL , TessinI , FallO , EriksonM , MatssonLA . A comparison of neonatal infectious outcome comparing two expectant managements of women with prelabor rupture of the membranes at 34‐42 weeks. American Journal of Obstetrics and Gynecology1998;178(1 Pt 2):S197. ">Ladfors 1996</a>; <a href="./references#CD004735-bbs2-0024" title="MateosD , CararachV , SentisJ , BotetF , FiguerasF , ArimanyM , et al. Cervical prostaglandin E2 compared with expectant management or systematic induction in premature rupture of the membranes with bad cervical conditions. Prenatal and Neonatal Medicine1998;1(Suppl 1):85. ">Mateos 1998</a>; <a href="./references#CD004735-bbs2-0028" title="VanHeerdenJ , SteynDW . Management of premature rupture of the membranes after 34 weeks' gestation ‐ early versus delayed induction of labour. South African Medical Journal1996;86:262‐6. ">Van Heerden 1996</a>) because the gestational age criteria for trial entry included women both prior to term and at term. We attempted to obtain information of the subgroup of women with PPROM prior to term in these trials; however, this was not successful. </p> <p>We excluded another five studies because they assessed interventions other than the effect of birth on maternal and fetal well‐being in women with PPROM (<a href="./references#CD004735-bbs2-0015" title="DecavalasG , MastrogiannisD , PapadopoulosV , TzingounisV . Short‐term vs long‐term prophylactic tocolysis in patients with preterm premature rupture of membranes. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology1995;59:143‐7. DecavalasG , PapadopoulosV , TsapanosV , TzingounisV . Tocolysis in patients with preterm premature rupture of membranes has any effect on pregnancy outcome?. International Journal of Gynecology &amp; Obstetrics1994;46:26. ">Decavalas 1995</a>; <a href="./references#CD004735-bbs2-0016" title="El‐QarmalawiAM , ElmardiAA , SaddikM , El‐Abdel HadiF , ShakerSMA . A comparative randomized study of oral prostaglandin E2 (PGE2) tablets and intravenous oxytocin in induction of labor in patients with premature rupture of membranes before 37 weeks of pregnancy. International Journal of Gynecology &amp; Obstetrics1990;33:115‐9. ">El‐Qarmalawi 1990</a>; <a href="./references#CD004735-bbs2-0020" title="HaghighiL . Intravaginal misoprostol in preterm premature rupture of membranes with low Bishop scores. International Journal of Gynecology &amp; Obstetrics2006;94(2):121‐2. ">Haghighi 2006</a>; <a href="./references#CD004735-bbs2-0025" title="MiodovnikM , SmithPP . Management of prelabour rupture of the membranes at 32‐36 weeks with prostaglandin present in the vaginal pool. Personal communication1988. ">Miodovnik 1988</a>; <a href="./references#CD004735-bbs2-0027" title="Perez PicanolE , VernetM , ArmengolR , Perez AresC , LecumberriJ , GamissansO . Comparison of two different therapeutic attitudes in premature rupture of membranes. Journal of Perinatal Medicine1992;20:353. ">Perez 1992</a>). </p> <p>We excluded one study because it was available in abstract form only and did not quantify outcomes that we could include in a meta‐analysis (<a href="./references#CD004735-bbs2-0023" title="MakhloufAM , MoemenA , AbdelaleemK , AbdelaleemH . Induction versus expectant management in preterm premature rupture of membranes. Research activities on reproductive health: annual report of Assiut University Department of Obstetrics and Gynecology November 1997. Assiut University, Faculty of Medicine, 1997:12. ">Makhlouf 1997</a>). </p> <p><a href="./references#CD004735-bbs2-0021" title="LacazeN . Safety and efficacy study of intentional delivery in women with preterm and prelabour rupture of the membranes (ongoing trial). www.clinicaltrials.gov (accessed 21 March 2006)2006. ">Lacaze 2006</a> was moved from 'ongoing' in the previous review to 'excluded' in this review as the trial had been terminated due to poor recruitment and there were no outcome data available. </p> </section> </section> <section id="CD004735-sec-0099"> <h3 class="title">Risk of bias in included studies</h3> <p>Please see <a href="#CD004735-fig-0002">Figure 2</a> and <a href="#CD004735-fig-0003">Figure 3</a> for summary of risk of bias assessments. </p> <div class="figure" id="CD004735-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004735-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004735-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>The trials were of variable methodological quality but overall of low to unclear risk of bias. </p> <p>We assessed publication bias using funnel plots (<a href="./references#CD004735-bbs2-0055" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Sterne 2011</a>). We noted no visual asymmetry (<a href="#CD004735-fig-0004">Figure 4</a>; <a href="#CD004735-fig-0005">Figure 5</a>; <a href="#CD004735-fig-0006">Figure 6</a>; <a href="#CD004735-fig-0007">Figure 7</a>; <a href="#CD004735-fig-0008">Figure 8</a>; <a href="#CD004735-fig-0009">Figure 9</a>; <a href="#CD004735-fig-0010">Figure 10</a>; <a href="#CD004735-fig-0011">Figure 11</a>). </p> <div class="figure" id="CD004735-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.1 Neonatal infection/sepsis" data-id="CD004735-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.1 Neonatal infection/sepsis </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.3 Respiratory distress syndrome" data-id="CD004735-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.3 Respiratory distress syndrome </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.4 Caesarean section" data-id="CD004735-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.4 Caesarean section </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.5 Perinatal mortality" data-id="CD004735-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.5 Perinatal mortality </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.6 Intrauterine death" data-id="CD004735-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.6 Intrauterine death </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.9 Neonatal death" data-id="CD004735-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.9 Neonatal death </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0010"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 10</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.15 Birthweight (g)" data-id="CD004735-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG10.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.15 Birthweight (g) </p> </div> </div> </div> <div class="figure" id="CD004735-fig-0011"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 11</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.31 Vaginal birth" data-id="CD004735-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG11.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.31 Vaginal birth </p> </div> </div> </div> <section id="CD004735-sec-0100"> <h4 class="title">Sensitivity analysis</h4> <p>We did not perform sensitivity analyses for this version of the review, due to very small differences in the potential risk of bias between the included studies. We assessed heterogeneity with subgroup analyses of outcomes. </p> </section> <section id="CD004735-sec-0101"> <h4 class="title">Allocation</h4> <section id="CD004735-sec-0102"> <h5 class="title">Random sequence generation</h5> <p>Ten of the 12 included trials discussed the method of randomisation (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>). This involved computer‐generated randomisation sequences, randomisation cards and random number tables. <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> and <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> did not report on the method of randomisation. </p> </section> <section id="CD004735-sec-0103"> <h5 class="title">Allocation concealment</h5> <p>Allocation concealment was unclear in all of the studies except <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> and <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> each of which were considered low risk of bias. </p> </section> </section> <section id="CD004735-sec-0104"> <h4 class="title">Blinding</h4> <section id="CD004735-sec-0105"> <h5 class="title">Blinding of participants and personnel (performance bias)</h5> <p>Blinding was not possible due to the intervention, however this is likely low risk of bias due to objective and specific assessment criteria for outcomes, where lack of blinding would not affect treatment decisions or other aspects of care. However, for one trial (<a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>), the risk was unclear as the assessment criteria for outcomes was not mentioned. </p> </section> <section id="CD004735-sec-0106"> <h5 class="title">Blinding of outcome assessment (detection bias)</h5> <p>Blinding of outcome assessors was only performed in three of the included trials (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>). In one trial (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>), only radiologists for reviewing X‐rays prior to diagnosis of hyaline membrane disease were blinded as to treatment allocation. It is not clear in the other trials whether outcome assessors were blinded to treatment allocation. </p> </section> </section> <section id="CD004735-sec-0107"> <h4 class="title">Incomplete outcome data</h4> <p>All of the trials reported on short‐term outcomes. The only trials that assessed any maternal or neonatal outcomes after discharge from hospital were <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>, which reported on neurodevelopmental outcomes at two years of age, and <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>, which reported on maternal satisfaction and breastfeeding duration greater than 12 weeks. There was incomplete outcome data in four of the studies (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>). <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> showed results inconsistent with the number randomised. There was no explanation to account for the inconsistencies and incomplete data. <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> removed a fetal death that occurred in the expectant management group from the denominator of neonatal outcomes. <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> excluded five women from analysis after randomisation. Three of these women were randomised to the expectant management group and were discharged home and they subsequently delivered their babies in another hospital and were excluded from analysis. Another mother and baby were excluded (also in this trial) due to failure to complete steroid therapy, and an additional neonate was excluded post‐randomisation due to the presence of congential abnormalities. <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> excluded 15 women on case review after randomisation. Seven of these women were excluded for preterm labour, four for protocol violation and four others for unspecified reasons. In addition, two perinatal deaths resulting from lethal congenital anomalies were excluded in this trial after randomisation. </p> </section> <section id="CD004735-sec-0108"> <h4 class="title">Selective reporting</h4> <p>Selective reporting bias was considered high in two of the trials. Although <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> was a published abstract only, in which three outcomes as well as secondary unspecified outcomes were reported, the full paper has not yet been published despite completion of the trial in 2011. In <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>, outcomes were only reported in results, and not pre‐specified. Although the inclusion criteria was singleton pregnancy only, results for caesarean section indicate there were two sets of twins in each group, which was not reported. </p> </section> <section id="CD004735-sec-0109"> <h4 class="title">Other potential sources of bias</h4> <p>As <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> was a published abstract only, it was unclear as to whether or not there were other sources of bias. We did not identify other potential sources of bias in any of the other included studies. </p> </section> </section> <section id="CD004735-sec-0110"> <h3 class="title" id="CD004735-sec-0110">Effects of interventions</h3> <p>See: <a href="./full#CD004735-tbl-0001"><b>Summary of findings for the main comparison</b> Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</a> </p> <p>We included 12 randomised controlled trials in this review. This included 3617 women and 3628 babies with preterm premature rupture of the membranes randomised to either planned early birth or expectant management. </p> <section id="CD004735-sec-0111"> <h4 class="title">Primary outcomes</h4> <section id="CD004735-sec-0112"> <h5 class="title">Fetal/neonatal outcomes</h5> <section id="CD004735-sec-0113"> <h6 class="title">Infection</h6> <p>We identified no clear differences in the primary outcomes of probable or definite neonatal sepsis, or both (risk ratio (RR) 0.93, 95% confidence interval (CI) 0.66 to 1.30, 12 trials, 3628 babies, evidence graded moderate, <a href="./references#CD004735-fig-0012" title="">Analysis 1.1</a>), or proven neonatal infection with positive blood culture (RR 1.24, 95% CI 0.70 to 2.21, seven trials, 2925 babies, <a href="./references#CD004735-fig-0013" title="">Analysis 1.2</a>). No separate data were available for proven neonatal infection with a positive blood culture specifically within 48 hours of birth or after 48 hours of birth. Therefore, we further categorised neonatal sepsis into subgroups of: neonatal sepsis proven with positive blood culture (and included those trials that specified their sepsis outcome was defined by a positive culture); presumed sepsis; and neonatal treatment with antibiotics. </p> <p>Three trials (<a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) reported on suspected neonatal sepsis and found a reduction associated with early birth (RR 0.56, 95% CI 0.36 to 0.88, 829 babies, <a href="./references#CD004735-fig-0021" title="">Analysis 1.10</a>). </p> </section> <section id="CD004735-sec-0114"> <h6 class="title">Respiratory distress syndrome</h6> <p>Early birth increased the incidence of respiratory distress syndrome (RDS) (RR 1.26, 95% CI 1.05 to 1.53, 12 trials, 3622 babies, evidence graded high, <a href="./references#CD004735-fig-0014" title="">Analysis 1.3</a>). Included in this outcome is <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> who included RDS in the definition of "transient pulmonary insufficiency" along with respiratory insufficiency of prematurity and transient tachypnoea of the newborn. Three trials included a sub‐category of severe respiratory distress, which showed no difference between the two groups (RR 1.54, 95% CI 0.80 to 2.97, three trials, 321 babies, <a href="./references#CD004735-fig-0032" title="">Analysis 1.21</a>). However, the definition of severe respiratory distress differed between the trials, and the numbers were too small to adequately assess this outcome. </p> </section> </section> <section id="CD004735-sec-0115"> <h5 class="title">Maternal outcomes</h5> <section id="CD004735-sec-0116"> <h6 class="title">Caesarean section</h6> <p>Early birth was associated with an increased rate of caesarean section (RR 1.26, 95% CI 1.11 to 1.44, 12 trials, 3620 women, evidence graded high, <a href="./references#CD004735-fig-0015" title="">Analysis 1.4</a>). </p> </section> </section> </section> <section id="CD004735-sec-0117"> <h4 class="title">Secondary outcomes</h4> <section id="CD004735-sec-0118"> <h5 class="title">Fetal outcomes</h5> <p>There was no clear difference in the overall perinatal mortality (RR 1.76, 95% CI 0.89 to 3.50, 11 trials, 3319 babies, <a href="./references#CD004735-fig-0016" title="">Analysis 1.5</a>), or intrauterine deaths (RR 0.45, 95% CI 0.13 to 1.55, 11 trials, 3321 babies, <a href="./references#CD004735-fig-0017" title="">Analysis 1.6</a>) when comparing early birth with expectant management. There was no difference in incidence of cord prolapse (RR 1.24, 95% CI 0.33 to 4.61, four trials, 2722 babies, <a href="./references#CD004735-fig-0018" title="">Analysis 1.7</a>). Babies of women randomised to early birth tended to be born at a gestational age lower than those randomised to expectant management (mean difference (MD) ‐0.48 weeks, 95% CI ‐0.57 to ‐0.39, eight trials, 3139 babies, <a href="./references#CD004735-fig-0019" title="">Analysis 1.8</a>). </p> </section> <section id="CD004735-sec-0119"> <h5 class="title">Neonatal outcomes</h5> <section id="CD004735-sec-0120"> <h6 class="title">Neonatal mortality</h6> <p>Early birth was associated with a higher rate of neonatal death (RR 2.55, 95% CI 1.17 to 5.56, 11 trials, 3316 babies, <a href="./references#CD004735-fig-0020" title="">Analysis 1.9</a>). There was a disproportionate increased number of deaths in the planned early delivery arm of one trial (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>). This was the only trial comparing a fetal lung maturity protocol using intravenous aminophylline every eight hours in the early‐birth arm and weekly in the expectant‐management arm. </p> </section> <section id="CD004735-sec-0121"> <h6 class="title">Neonatal morbidity</h6> <p>Early birth was associated with an increased need for neonatal ventilation (RR 1.27, 95% CI 1.02 to 1.58, seven trials, 2895 babies, evidence graded high, <a href="./references#CD004735-fig-0023" title="">Analysis 1.12</a>) and increased the arterial pH in the umbilical cord to above the normal range (MD 0.09, 95% CI 0.07 to 0.11, one trial, 120 babies, <a href="./references#CD004735-fig-0025" title="">Analysis 1.14</a>). </p> <p>There were no clear differences between the groups in other measures of neonatal morbidities, including neonatal treatment with antibiotics (average RR 0.86, 95% CI 0.63 to 1.19, four trials, 2638 babies, Tau² = 0.08, I²<i>=</i> 80%<i>,</i><a href="./references#CD004735-fig-0022" title="">Analysis 1.11)</a>, days of oxygen therapy (RR ‐3.05, 95% CI ‐6.92 to 0.82, one trial, 73 babies, <a href="./references#CD004735-fig-0024" title="">Analysis 1.13</a>), birthweight (MD ‐47.10 g, 95% CI ‐96.00 to 1.80), 10 trials, 3263 babies, Tau² = 2260.76, I² = 44%, <a href="./references#CD004735-fig-0026" title="">Analysis 1.15</a>), Apgar score less than seven at five minutes (RR 0.96, 95% CI 0.54 to 1.69, five trials, 2700 babies, <a href="./references#CD004735-fig-0027" title="">Analysis 1.16</a>), abnormality on cerebral ultrasound (RR 1.90, 95% CI 0.52 to 6.92, three trials, 271 babies, <a href="./references#CD004735-fig-0028" title="">Analysis 1.17</a>), periventricular leukomalacia (RR 1.00, 95% CI 0.14 to 6.99, two trials, 707 babies, <a href="./references#CD004735-fig-0029" title="">Analysis 1.18</a>), cerebroventricular haemorrhage (RR 1.19, 95% CI 0.40 to 3.52, six trials, 1095 babies, <a href="./references#CD004735-fig-0030" title="">Analysis 1.19</a>), and necrotising enterocolitis (RR 0.81, 95% CI 0.25 to 2.62, six trials, 2842 babies, <a href="./references#CD004735-fig-0031" title="">Analysis 1.20</a>). </p> <p>There was substantial heterogeneity between the trials in assessing neonatal treatment with antibiotics as demonstrated by an I² of 80%. This was likely due to the differences in clinical practice guidelines between sites regarding antibiotic use. There was also high heterogeneity for birthweight which was likely due to the differences in gestational age at randomisation between trials. </p> </section> <section id="CD004735-sec-0122"> <h6 class="title">Neonatal hospitalisation</h6> <p>Admission to neonatal intensive care (RR 1.16, 95% CI 1.08 to 1.24, four trials, 2691 babies, evidence graded moderate, <a href="./references#CD004735-fig-0033" title="">Analysis 1.22</a>) was higher for those babies randomised to early birth. However, the length of stay in neonatal intensive care for those babies who were admitted to the neonatal intensive care unit (NICU) was no different between the two groups (MD ‐0.17 days, 95% CI ‐1.62 to 1.27, four trials, 2121 babies, Tau² = 1.65, I² = 85%, <a href="./references#CD004735-fig-0034" title="">Analysis 1.23</a>). This may suggest that although fewer babies in the expectant management arm were admitted to NICU, their length of stay in NICU was longer. Furthermore, the duration of days in NICU for one trial (<a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>) was considerably longer than the other three trials that assessed this outcome. This may be attributed to the earlier gestation at randomisation (28 to 34 weeks as compared to 34 to 36 + 6 weeks) as well as being the oldest of the four trials (1985). Changes in clinical practice over time may have influenced time spent in NICU. Two trials (<a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) were excluded from this outcome on the advice of the study author as there was uncertainty regarding the denominator used for the analysis. Overall duration of neonatal hospitalisation (MD 0.67 days, 95% CI ‐0.28 to 1.61, six trials, 2832 babies, Tau² = 0.80, I² = 71%, <a href="./references#CD004735-fig-0035" title="">Analysis 1.24</a>) was also no different between those babies in the early birth group compared to the expectant management group. </p> <p>Heterogeneity for all these outcomes was high. This was likely due to the differences in clinical practice as evidenced by the large number of countries and sites represented in this review. Many hospitals routinely admit babies where the pregnancy is complicated by PPROM to NICU for observation for a specified period of time, whereas others do not. </p> </section> <section id="CD004735-sec-0123"> <h6 class="title">Long‐term disability</h6> <p>There were no clear differences in neurodevelopmental outcomes at two years of age between children in the early birth group compared to children in the expectant when assessed by the Child Behaviour Checklist (CBCL) (RR 0.64, 95% CI 0.26 to 1.59, one trial, 199 babies, <a href="./references#CD004735-fig-0049" title="">Analysis 1.38</a>) or the Ages and Stages Questionnaire (ASQ) (RR 0.61, 95% CI 0.35 to 1.05, one trial, 228 babies, <a href="./references#CD004735-fig-0050" title="">Analysis 1.39</a>). However, the trial was not powered for this outcome and with a 45% follow‐up rate, the numbers may be insufficient for an overall effect. </p> </section> </section> <section id="CD004735-sec-0124"> <h5 class="title">Maternal outcomes</h5> <section id="CD004735-sec-0125"> <h6 class="title">Infection</h6> <p>In assessing maternal outcomes, we found that early birth was associated with a decreased rate of chorioamnionitis (average RR 0.50, 95% CI 0.26 to 0.95, eight trials, 1358 women, evidence graded moderate, Tau² = 0.36, I² = 48%, <a href="./references#CD004735-fig-0036" title="">Analysis 1.25</a>). However, early birth was associated with an increased rate of endometritis (RR 1.61, 95% CI 1.00 to 2.59, seven trials, 2980 women, <a href="./references#CD004735-fig-0037" title="">Analysis 1.26</a>). There was no difference between early planned birth and expectant management in the risk of postpartum fever (RR 0.52, 95% CI 0.26 to 1.03, one trial, 1835 women, <a href="./references#CD004735-fig-0038" title="">Analysis 1.27</a>). </p> <p>There was substantial heterogeneity between the trials in assessing chorioamnionitis as demonstrated by an I² of 48%. To analyse the source of heterogeneity we performed a number of subgroup analyses. The subgroup analysis comparing those trials in which early birth occurred less than 24 hours after randomisation reduced chorioamnionitis (RR 0.22, 95% CI 0.17 to 0.55, three trials, 342 women), while no difference was seen when planned birth was 24 hours or more from randomisation (RR 1.10, 95% CI 0.62 to 1.95, five trials, 1016 women). An interaction test for this difference between subgroups was significant in assessing the subgroup of early birth on chorioamnionitis: Chi² = 6.02, df = 1 (P = 0.01), I² = 83.4%, <a href="./references#CD004735-fig-0075" title="">Analysis 5.5</a>). Likewise, the subgroup analysis for gestational age at randomisation showed a reduction in chorioamnionitis in women greater than 34 weeks' gestation (RR 0.26, 95% CI 0.12 to 0.57, three trials, 847 women) compared to women less than 34 weeks' gestation (RR 0.77, 95% CI 0.45 to 1.30, four trials, 418 women). However, the interaction test for subgroup differences was not significant, <a href="./references#CD004735-fig-0063" title="">Analysis 3.5</a>. </p> </section> <section id="CD004735-sec-0126"> <h6 class="title">Other complications</h6> <p>There were no clear differences in rates of placental abruption between the two groups (RR 1.19, 95% CI 0.36 to 3.87, one trial, 1835 women, <a href="./references#CD004735-fig-0039" title="">Analysis 1.28</a>). </p> </section> <section id="CD004735-sec-0127"> <h6 class="title">Mode of birth</h6> <p>As expected due to the intervention, women randomised to early birth had a higher chance of having an induction of labour as compared to women randomised to expectant management (RR 2.18, 95% CI 2.01 to 2.36, four trials, 2691 women, <a href="./references#CD004735-fig-0040" title="">Analysis 1.29</a>). In <a href="./references#CD004735-fig-0041" title="">Analysis 1.30</a>, the results were probably in favour of the expectant management group, with more women in the planned early birth group using spinal/epidural anaesthesia (average RR 1.28, 95% CI 0.99 to 1.65, three trials, 2562 women, Tau² = 0.03, I² <i>=</i> 57%<i>,</i><a href="./references#CD004735-fig-0041" title="">Analysis 1.30</a>). The high heterogeneity for this outcome was likely due to the differences in clinical practice between sites regarding the availability and use of epidural/spinal anaesthesia. The chances of a vaginal birth were lower in women randomised to early birth (RR 0.94, 95% CI 0.91 to 0.97, 12 trials, 3618 women, <a href="./references#CD004735-fig-0042" title="">Analysis 1.31</a>), although the rate of operative vaginal birth showed no difference (RR 0.85, 95% CI 0.67 to 1.10, four trials, 2685 women, <a href="./references#CD004735-fig-0043" title="">Analysis 1.32</a>). Although caesarean section rates were higher in the early birth group, if the reason for the caesarean section was fetal distress, the difference between the early birth group and the expectant management group was not apparent (RR 0.89, 95% CI 0.66 to 1.20, seven trials, 2918 women, <a href="./references#CD004735-fig-0044" title="">Analysis 1.33</a>). </p> </section> <section id="CD004735-sec-0128"> <h6 class="title">Duration of maternal hospital stay</h6> <p>Women randomised to early birth showed a decrease in the total length of hospitalisation (MD ‐1.75 days, 95% CI ‐2.45 to ‐1.05, six trials, 2848 women, Tau² = 0.41, I² = 63%, <a href="./references#CD004735-fig-0045" title="">Analysis 1.34</a>), including the length of antenatal hospitalisation (MD ‐6.30 days, 95% CI ‐9.67 to ‐2.93, one trial, 73 women, <a href="./references#CD004735-fig-0044" title="">Analysis 1.33</a>). This result remained consistent in trials which allowed for antenatal discharge between randomisation and birth (MD ‐1.64 days, 95% CI ‐3.06 to ‐0.23, two trials, 213 women, Tau² = 0.65, I² = 58%, <a href="./references#CD004735-fig-0047" title="">Analysis 1.36</a>). The differences in patient admission management between different sites and countries likely accounted for the high heterogeneity regarding duration of maternal hospital stay. </p> </section> <section id="CD004735-sec-0129"> <h6 class="title">Time from randomisation to birth</h6> <p>As expected, the time from randomisation to birth was shorter for those randomised to early birth (MD ‐79.48 hours, 95% CI ‐88.27 to ‐70.69, three trials, 2571 women, <a href="./references#CD004735-fig-0048" title="">Analysis 1.37</a>). </p> </section> <section id="CD004735-sec-0130"> <h6 class="title">Satisfaction and breastfeeding</h6> <p>There was no difference in overall maternal satisfaction relating to their birth experience when comparing early birth with expectant management (RR 0.99, 95% CI 0.86 to 1.13, one trial, 493 women, <a href="./references#CD004735-fig-0051" title="">Analysis 1.40</a>). Likewise there was no difference between the two groups in the number of women who continued to breast feed for longer than 12 weeks following birth (RR 0.95, 95% CI 0.80 to 1.12, one trial, 415 women, <a href="./references#CD004735-fig-0052" title="">Analysis 1.41</a>). </p> </section> </section> </section> <section id="CD004735-sec-0131"> <h4 class="title">Subgroup analyses</h4> <section id="CD004735-sec-0132"> <h5 class="title">Antenatal corticosteroids</h5> <p>The trials differed in their use of antenatal corticosteroids in randomised women. Five trials (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) did not give antenatal corticosteroids to any of their randomised participants. Two trials (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>) gave corticosteroids to the women randomised to early birth and not to women randomised to expectant management. One trial (<a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>) gave corticosteroids only to one group of women randomised to early birth and not to the second group or to the expectant management group. One trial (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>) used corticosteroids according to local protocol, and two trials (<a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) gave corticosteroids to women who ruptured their membranes prior to 34 weeks' gestation. No trials gave antenatal corticosteroids to all their randomised participants. <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> did not stipulate corticosteroid usage. </p> <p>There was no evidence of a difference between subgroups for corticosteroid use for the following outcomes: neonatal infection, <a href="./references#CD004735-fig-0053" title="">Analysis 2.1</a>, neonatal infection confirmed with positive culture, <a href="./references#CD004735-fig-0054" title="">Analysis 2.2</a>, RDS, <a href="./references#CD004735-fig-0055" title="">Analysis 2.3</a>, caesarean section, <a href="./references#CD004735-fig-0056" title="">Analysis 2.4</a>, chorioamnionitis, <a href="./references#CD004735-fig-0057" title="">Analysis 2.5</a>, and endometritis, <a href="./references#CD004735-fig-0058" title="">Analysis 2.6</a>, between trials in which no antenatal corticosteroids were used and trials where some antenatal corticosteroids were used. </p> </section> <section id="CD004735-sec-0133"> <h5 class="title">Gestational age</h5> <p>Five trials (<a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a>; <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) randomised women greater than 34 weeks' gestation, and five trials (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>) randomised women less than 34 weeks' gestation. Two trials (<a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) included women before and after 34 weeks' gestation. </p> <p>The test for subgroup differences were not significant for neonatal infection (<a href="./references#CD004735-fig-0059" title="">Analysis 3.1</a>), neonatal infection confirmed with positive culture (<a href="./references#CD004735-fig-0060" title="">Analysis 3.2</a>), RDS (<a href="./references#CD004735-fig-0061" title="">Analysis 3.3</a>), caesarean section, (<a href="./references#CD004735-fig-0062" title="">Analysis 3.4</a>), and chorioamnionitis (<a href="./references#CD004735-fig-0063" title="">Analysis 3.5</a>) between trials that randomised women after 34 weeks' gestation compared to before 34 weeks' gestation. There was a decrease in endometritis in women randomised to early delivery in trials greater than 34 weeks' gestation (RR 0.37, 95% CI 0.10 to 1.40, three trials, 2562 women) compared to women randomised in trials less than 34 weeks' gestation (RR 2.23, 95% CI 1.29 to 3.84, four trials, 418 women). The test for subgroup differences showed: Chi² = 5.99, df = 1 (P = 0.01), I² = 83.3%, <a href="./references#CD004735-fig-0064" title="">Analysis 3.6</a>. There were overall effect differences in RDS and chorioamnionitis showing an increase in RDS in early delivery in trials that recruited women greater than 34 weeks' gestation (RR 1.45, 95% CI 1.10 to 1.90, five trials, 2992 babies), and a decrease in chorioamnionitis in expectant management in trials that recruited women greater than 34 weeks' gestation (RR 0.26, 95% CI 0.12 to 0.57, three trials, 847 women). This may suggest better infant and maternal outcomes related to expectant management after 34 weeks' gestation. However, these results must be interpreted with caution as there were considerably fewer women in the subgroup less than 34 weeks' gestation compared to more than 34 weeks' gestation. </p> </section> <section id="CD004735-sec-0134"> <h5 class="title">Prophylactic antibiotics</h5> <p>One trial (<a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>) gave prophylactic antibiotics to all women randomised to the trial. Seven trials (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>; <a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>; <a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) did not use prophylactic antibiotics. Three trials (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a>; <a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) used prophylactic antibiotics according to local protocol which differed between sites. <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> provided individual participant data regarding the use of antibiotics for the outcome of neonatal sepsis. <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> did not mention whether they used prophylactic antibiotics. </p> <p>The test for subgroup differences were not significant for neonatal infection (<a href="./references#CD004735-fig-0065" title="">Analysis 4.1</a>), neonatal infection confirmed with positive blood culture (<a href="./references#CD004735-fig-0066" title="">Analysis 4.2</a>), RDS (<a href="./references#CD004735-fig-0067" title="">Analysis 4.3</a>), caesarean section (<a href="./references#CD004735-fig-0068" title="">Analysis 4.4</a>), or chorioamnionitis (<a href="./references#CD004735-fig-0069" title="">Analysis 4.5</a>), between trials whether all, none or some women received prophylactic antibiotics. However, there was an increase in endometritis in women randomised to early birth in trials that did not use prophylactic antibiotics (RR 2.23, 95% CI 1.29 to 3.84, four trials, 418 women) as compared to trials where some women received prophylactic antibiotics (RR 0.37, 95% CI 0.10 to 1.40, three trials, 2562 women). The test for subgroup differences showed: Chi² = 5.99, df = 1 (P = 0.01), I² = 83.3%, <a href="./references#CD004735-fig-0070" title="">Analysis 4.6</a>. Overall effect differences showed a decrease in chorioamnionitis in expectant management when all or some prophylactic antibiotics were used, suggesting that antibiotics were effective in reducing maternal infections. Again, the results for this subgroup analysis must be interpreted with caution due to the considerably increased number of women in the 'some antibiotics' category compared to those who did not receive antibiotics. Independent participant data analysis would be useful to assess this more comprehensively. </p> </section> <section id="CD004735-sec-0135"> <h5 class="title">Timing of birth</h5> <p>The timing of intervention for early birth differed between the studies. The mean latency from PROM to birth in four studies (<a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a>; <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a>; <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998;</a><a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a>) indicated that early birth was planned for less than 24 hours, even though this was not explicitly stated. One study (<a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a>) did not indicate when birth was intended but results indicated a median latency of three days. Three studies (<a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a>; <a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a>; <a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a>) planned for women in the early birth arm to give birth more than 24 hours after randomisation. Three studies (<a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a>; <a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a><a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a>) intended for women randomised to early birth to have labour initiated within 24 hours. However, the mean latency from randomisation to birth in these trials ranged from 33.9 to 39 hours. <a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> did not indicate or provide data to support timing of early birth. Because of the lack of information related to 'intention' of timing of delivery in four of the trials, we based subgroup analysis on mean latency results rather than intended timing of early birth. </p> <p>Subgroup analysis by timing of birth showed the tests for subgroup differences were not significant for neonatal sepsis (<a href="./references#CD004735-fig-0071" title="">Analysis 5.1</a>), neonatal infection confirmed with positive blood culture (<a href="./references#CD004735-fig-0072" title="">Analysis 5.2</a>), RDS (<a href="./references#CD004735-fig-0073" title="">Analysis 5.3</a>), caesarean section (<a href="./references#CD004735-fig-0074" title="">Analysis 5.4</a>), and endometritis (<a href="./references#CD004735-fig-0076" title="">Analysis 5.6)</a> between trials where early birth occurred less than 24 hours after randomisation as compared to trials where early birth occurred more than 24 hours after randomisation. However, chorioamnionitis was reduced in women randomised to early birth when planned birth occurred within 24 hours (RR 0.25, 95% CI 0.10 to 0.61, three trials, 342 women) as compared to when planned birth occurred more than 24 hours from randomisation (RR 0.76, 95% CI 0.41 to 1.42, five trials, 1016 women). The test for subgroup differences showed: Chi² = 4.06, df = 1 (P = 0.04), I² = 75.4%, <a href="./references#CD004735-fig-0075" title="">Analysis 5.5</a>. </p> </section> </section> <section id="CD004735-sec-0136"> <h4 class="title">Outcomes not able to be assessed</h4> <p>There were no data related to secondary neonatal outcomes of treatment with surfactant, days of neonatal ventilation, oxygen therapy at 36 weeks' postmenstrual age, or admission to NICU after 24 hours. </p> <p>There were no data related to secondary maternal outcomes of mode of induction of labour and days of postnatal hospitalisation. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004735-sec-0137" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004735-sec-0137"></div> <section id="CD004735-sec-0138"> <h3 class="title" id="CD004735-sec-0138">Summary of main results</h3> <p>The existing evidence arose from clinical trials in which the protocols differed in their management of women with preterm prelabour rupture of the membranes (PPROM), particularly the use of prophylactic antibiotics, use of corticosteroids, timing of early birth and gestational age at trial entry. However, subgroup analyses of these four factors did not alter the result of the primary outcome of sepsis, which indicated that there was no difference in the incidence of neonatal sepsis between women who gave birth immediately or were managed expectantly in PPROM prior to 37 weeks' gestation. </p> <p>Planned early birth was associated with an increase in the incidence of neonatal RDS, neonatal mortality and the likelihood of birth by caesarean section. Babies in the early birth arm were more likely to be admitted to neonatal intensive care unit, and receive ventilatory support. </p> <p>Maternal outcomes indicated early birth was associated with an increased likelihood of induction of labour and endometritis, which was reduced with the use of antenatal antibiotics, and a decreased incidence of chorioamnionitis. The clinical significance of the decreased likelihood of chorioamnionitis following early planned birth but an increased risk of endometritis is difficult to interpret. Chorioamnionitis was defined clinically and by those not blinded to treatment allocation so there is a possibility of bias in reporting this outcome. Long term follow‐up studies are necessary to ascertain whether there are any sequelae beyond the neonatal period that may result from these exposures. Chorioamnionitis was decreased when randomisation occurred greater than 34 weeks of gestation and if birth occurred within 24 hours of randomisation. However, not all trials assessed this outcome on women randomised to early birth as the presence of chorioamnionitis was an exclusion criteria. The length of time between randomisation and birth as well as overall length of maternal hospitalisation was longer in women randomised to expectant management. The three trials which reported on suspected neonatal infection showed an increase in babies who were managed expectantly, however the numbers were too small to be interpreted with confidence. </p> </section> <section id="CD004735-sec-0139"> <h3 class="title" id="CD004735-sec-0139">Overall completeness and applicability of evidence</h3> <p>The applicability of findings from the meta‐analysis to other populations and settings is limited by several factors. Firstly, the gestational age for inclusion into the studies was often wide. As the perinatal complications associated with PPROM change with gestational age, the management of women with a pregnancy complicated by PPROM requires a stratified approach based largely on gestational age. However, the addition of four trials with inclusion criteria between 34 and 37 weeks' gestation provided some meaningful gestational age‐based management for women at 34 or more weeks' gestation. </p> <p>Secondly, a number of trials included co‐interventions in addition to the timing of birth such as corticosteroids, tocolysis and antibiotics which may also limit the applicability of these findings. Since the publication of these earlier trials it has been clearly demonstrated that a number of these co‐interventions are of benefit for the mother and baby in the setting of PPROM. There is a beneficial effect for both the mother and the baby in the use of prophylactic erythromycin in the setting of PPROM (<a href="./references#CD004735-bbs2-0041" title="KenyonS , TaylorDJ , Tarnow‐MordiW . Broad spectrum antibiotics for preterm, prelabour rupture of the fetal membranes: the ORACLE I randomised trial. Lancet2001;357:979‐88. ">Kenyon 2001</a>; <a href="./references#CD004735-bbs2-0042" title="KenyonS , BoulvainM , NeilsonJ . Antibiotics for preterm premature rupture of the membranes. Cochrane Database of Systematic Reviews2003, Issue 2. [DOI: 10.1002/14651858.CD001058] ">Kenyon 2003</a>) similar to the demonstrated beneficial effects of antenatal corticosteroids for women with PPROM, particularly for the neonate at gestations less than 34 weeks (<a href="./references#CD004735-bbs2-0037" title="HardingJE , PangJM , KnightDB , LigginsGC . Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. American Journal of Obstetrics and Gynecology2001;184:131‐9. ">Harding 2001</a>). Only one of these trials (<a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a>) used prophylactic antibiotics for all women. However, <a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> provided data for those women who did receive prophylactic antibiotics that contributed a substantial number towards the analysis. None of the trials used corticosteroids for both the early birth and expectant management groups. Using corticosteroids for both the early birth and expectant management groups in women at gestations less than 34 weeks would have provided clinically meaningful information and would have removed the confounder of steroids in assessing the effect of early birth on maternal and neonatal outcomes. </p> </section> <section id="CD004735-sec-0140"> <h3 class="title" id="CD004735-sec-0140">Quality of the evidence</h3> <p>Overall, all 12 studies were assessed as being at low or unclear risk of bias. Some of the studies lacked an adequate description of methods and the risk of bias could only be assessed as unclear. In five of the studies there were one or two domains where the we judged the risk of bias as high. However, this was unlikely to change the magnitude of effect. We used GRADE profiling to assess neonatal outcomes of infection/sepsis, RDS, need for ventilation, and admission to NICU: and maternal outcomes of caesarean section, chorioamnionitis, and length of hospital stay. The results show the quality of evidence across all critical outcomes to be moderate to high. Downgrading was mainly due to imprecision where few events resulted in wide confidence intervals, and inconsistency as evidenced by heterogeneity. </p> </section> <section id="CD004735-sec-0141"> <h3 class="title" id="CD004735-sec-0141">Potential biases in the review process</h3> <p>The inclusion criteria for this review were intentionally broad, with the aim of being able to better examine all of the possible evidence available. These trials differed with respect to inclusion criteria, co‐interventions and the timing of the early birth intervention. The results provided by the subgroup analysis should be interpreted with caution due to the large differences in numbers of women between the subgroups. </p> <p>We acknowledge that there was the potential for bias at all stages in the reviewing process. We attempted to minimise bias in a number of ways; for example, two review authors independently carried out data extraction and assessed risk of bias. David P van der Ham was Chief Investigator and first author of the PPROMEXIL trials and so JM and DB were responsible for data extraction and assessment of all trial reports relating to this study. Jonathan Morris was the Chief Investigator and first author for the NHMRC‐ (National Health and Medical Research Council) funded PPROMT trial and so data was assessed and extracted independently by PM. However, we acknowledge that such assessments involve subjective judgments, and another review team may not have agreed with all of our decisions. </p> </section> <section id="CD004735-sec-0142"> <h3 class="title" id="CD004735-sec-0142">Agreements and disagreements with other studies or reviews</h3> <p>We are not aware of any other reviews addressing this question. Most of the studies included in this review concur with expectant management as not having an increased risk to neonatal outcomes. The exceptions are <a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> and <a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a> which concluded that early birth resulted in decreased infection for both mothers and infants. However, these trials were underpowered to adequately assess this outcome. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004735-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD004735-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD004735-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD004735-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.1 Neonatal infection/sepsis" data-id="CD004735-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.1 Neonatal infection/sepsis </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.3 Respiratory distress syndrome" data-id="CD004735-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.3 Respiratory distress syndrome </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.4 Caesarean section" data-id="CD004735-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.4 Caesarean section </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.5 Perinatal mortality" data-id="CD004735-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.5 Perinatal mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.6 Intrauterine death" data-id="CD004735-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.6 Intrauterine death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.9 Neonatal death" data-id="CD004735-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.9 Neonatal death </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG10.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.15 Birthweight (g)" data-id="CD004735-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 10</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.15 Birthweight (g) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-AFig-FIG11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-AFig-FIG11.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.31 Vaginal birth" data-id="CD004735-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 11</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Any planned birth versus expectant management: by type, outcome: 1.31 Vaginal birth </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-AFig-FIG11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 1 Neonatal infection/sepsis." data-id="CD004735-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 1 Neonatal infection/sepsis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 2 Neonatal infection confirmed with positive blood culture." data-id="CD004735-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 2 Neonatal infection confirmed with positive blood culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 3 Respiratory distress syndrome." data-id="CD004735-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-04.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 4 Caesarean section." data-id="CD004735-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 5 Perinatal mortality." data-id="CD004735-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 5 Perinatal mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-06.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 6 Intrauterine death." data-id="CD004735-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 6 Intrauterine death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 7 Cord prolapse." data-id="CD004735-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 7 Cord prolapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 8 Gestational age at birth (weeks)." data-id="CD004735-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 8 Gestational age at birth (weeks). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-09.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 9 Neonatal death." data-id="CD004735-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 9 Neonatal death. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 10 Suspected neonatal infection." data-id="CD004735-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 10 Suspected neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 11 Neonatal treatment with antibiotics." data-id="CD004735-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 11 Neonatal treatment with antibiotics. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 12 Need for ventilation." data-id="CD004735-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 12 Need for ventilation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 13 Duration of oxygen therapy (days)." data-id="CD004735-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 13 Duration of oxygen therapy (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 14 Umbilical cord arterial pH." data-id="CD004735-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 14 Umbilical cord arterial pH. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-15.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 15 Birthweight (g)." data-id="CD004735-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 15 Birthweight (g). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 16 Apgar score less than 7 at 5 minutes." data-id="CD004735-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 16 Apgar score less than 7 at 5 minutes. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 17 Abnormality on cerebral ultrasound." data-id="CD004735-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 17 Abnormality on cerebral ultrasound. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 18 Periventricular leukomalacia." data-id="CD004735-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 18 Periventricular leukomalacia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 19 Cerebroventricular haemorrhage." data-id="CD004735-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 19 Cerebroventricular haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 20 Necrotising enterocolitis." data-id="CD004735-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 20 Necrotising enterocolitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 21 Severe respiratory distress." data-id="CD004735-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 21 Severe respiratory distress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 22 Admission to neonatal intensive care unit." data-id="CD004735-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 22 Admission to neonatal intensive care unit. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-23" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-23.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 23 Length of stay in neonatal intensive care unit (days)." data-id="CD004735-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-23.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 23 Length of stay in neonatal intensive care unit (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-23.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-24" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-24.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 24 Duration (days) from birth to neonatal hospital discharge." data-id="CD004735-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-24.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 24 Duration (days) from birth to neonatal hospital discharge. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-24.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-25" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-25.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 25 Chorioamnionitis." data-id="CD004735-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-25.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 25 Chorioamnionitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-25.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-26" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-26.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 26 Endometritis." data-id="CD004735-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-26.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 26 Endometritis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-26.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-27" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-27.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 27 Postpartum fever." data-id="CD004735-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-27.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 27 Postpartum fever. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-27.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-28" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-28.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 28 Placental abruption." data-id="CD004735-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-28.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 28 Placental abruption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-28.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-29" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-29.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 29 Induction of labour." data-id="CD004735-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-29.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 29 Induction of labour. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-29.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-30" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-30.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 30 Use of epidural/spinal anaesthesia." data-id="CD004735-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-30.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 30 Use of epidural/spinal anaesthesia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-30.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-31" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-31.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 31 Vaginal birth." data-id="CD004735-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-31.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 31 Vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-31.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-32" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-32.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 32 Operative vaginal birth." data-id="CD004735-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-32.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 32 Operative vaginal birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-32.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-33" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-33.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 33 Caesarean section for fetal distress." data-id="CD004735-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-33.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 33 Caesarean section for fetal distress. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-33.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-34" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-34.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 34 Duration (days) of maternal hospitalisation." data-id="CD004735-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-34.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 34 Duration (days) of maternal hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-34.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-35" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-35.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 35 Duration (days) of antenatal hospitalisation." data-id="CD004735-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-35.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 35 Duration (days) of antenatal hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-35.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-36" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-36.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 36 Duration (days) of maternal hospitalisation (excluding trials with antenatal discharge)." data-id="CD004735-fig-0047" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-36.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 36 Duration (days) of maternal hospitalisation (excluding trials with antenatal discharge). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-36.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-37" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-37.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 37 Time (hours) from randomisation to birth." data-id="CD004735-fig-0048" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-37.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 37 Time (hours) from randomisation to birth. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-37.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-38" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-38.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 38 Disability at 2 years, abnormal CBCL." data-id="CD004735-fig-0049" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-38.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 38 Disability at 2 years, abnormal CBCL. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-38.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-39" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-39.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 39 Disability at 2 years, abnormal ASQ." data-id="CD004735-fig-0050" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-39.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 39 Disability at 2 years, abnormal ASQ. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-39.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-40" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-40.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 40 Maternal satisfaction." data-id="CD004735-fig-0051" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-40.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 40 Maternal satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-40.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-001-41" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-001-41.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Any planned birth versus expectant management: by type, Outcome 41 Breastfeeding &gt; 12 weeks." data-id="CD004735-fig-0052" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-41.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1 Any planned birth versus expectant management: by type, Outcome 41 Breastfeeding &gt; 12 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-001-41.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 1 Neonatal infection." data-id="CD004735-fig-0053" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 1 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 2 Neonatal infection confirmed with positive culture." data-id="CD004735-fig-0054" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 2 Neonatal infection confirmed with positive culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 3 Respiratory distress syndrome." data-id="CD004735-fig-0055" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 4 Caesarean section." data-id="CD004735-fig-0056" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 5 Chorioamnionitis." data-id="CD004735-fig-0057" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 5 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 6 Endometritis." data-id="CD004735-fig-0058" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Any planned birth versus expectant management (subgroup analysis by corticosteroid usage), Outcome 6 Endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 1 Neonatal infection." data-id="CD004735-fig-0059" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 1 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 2 Neonatal infection confirmed with positive culture." data-id="CD004735-fig-0060" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 2 Neonatal infection confirmed with positive culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 3 Respiratory distress syndrome." data-id="CD004735-fig-0061" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 4 Caesarean section." data-id="CD004735-fig-0062" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 5 Chorioamnionitis." data-id="CD004735-fig-0063" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 5 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 6 Endometritis." data-id="CD004735-fig-0064" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial), Outcome 6 Endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 1 Neonatal infection." data-id="CD004735-fig-0065" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 1 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 2 Neonatal infection confirmed with positive culture." data-id="CD004735-fig-0066" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 2 Neonatal infection confirmed with positive culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 3 Respiratory distress syndrome." data-id="CD004735-fig-0067" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 4 Caesarean section." data-id="CD004735-fig-0068" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 5 Chorioamnionitis." data-id="CD004735-fig-0069" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 5 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 6 Endometritis." data-id="CD004735-fig-0070" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Any planned birth versus expectant management (subgroup analysis by antibiotic use), Outcome 6 Endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 1 Neonatal infection." data-id="CD004735-fig-0071" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 1 Neonatal infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 2 Neonatal infection confirmed with positive culture." data-id="CD004735-fig-0072" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 2 Neonatal infection confirmed with positive culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 3 Respiratory distress syndrome." data-id="CD004735-fig-0073" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 3 Respiratory distress syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 4 Caesarean section." data-id="CD004735-fig-0074" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 4 Caesarean section. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 5 Chorioamnionitis." data-id="CD004735-fig-0075" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 5 Chorioamnionitis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004735-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/urn:x-wiley:14651858:media:CD004735:CD004735-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_t/tCD004735-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 6 Endometritis." data-id="CD004735-fig-0076" src="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Any planned birth versus expectant management (subgroup analysis by timing of early delivery), Outcome 6 Endometritis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/media/CDSR/CD004735/image_n/nCD004735-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004735-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> women with preterm prelabour rupture of membranes prior to 37 weeks' gestation<br/> <b>Settings:</b> USA, the Netherlands, Mexico, Albania, Australia, New Zealand, Argentina, South Africa, Brazil, UK, Norway, Egypt, Uruguay, Poland, and Romania<br/> <b>Intervention:</b> planned early birth<br/> <b>Comparison:</b> expectant management </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Expectant management</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Planned early birth</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal infection/sepsis</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.93</b> <br/> (0.66 to 1.3) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3628<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>34 per 1000</b> <br/> (24 to 48) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Neonatal respiratory distress syndrome</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> <br/> (1.05 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3622<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>109 per 1000</b> <br/> (89 to 131) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Need for ventilation</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.27</b> <br/> (1.02 to 1.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2895<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>86 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>110 per 1000</b> <br/> (88 to 136) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Admission to neonatal intensive care</b> <br/> Follow‐up: 28 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.16</b> <br/> (1.08 to 1.24) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2691<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>428 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>497 per 1000</b> <br/> (462 to 531) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Caesarean section</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 1.26</b> <br/> (1.11 to 1.44) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3620<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/> <b>high</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>172 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>217 per 1000</b> <br/> (191 to 248) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Chorioamnionitis</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>RR 0.50</b> <br/> (0.26 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1358<br/> (8 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>103 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>51 per 1000</b> <br/> (27 to 98) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospital stay (maternal)</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay (maternal) in the expectant group was<br/> <b>7.6 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay (maternal) in the early birth group was <b>1.75 days lower</b> <br/> (2.45 to 1.05 lower) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐1.75</b> (‐2.45 to ‐1.05) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2848<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Wide confidence interval crossing the line of no effect, and the lines of appreciable benefit and harm.<br/> <sup>2</sup>Some statistical heterogeneity (I² = 48%).<br/> <sup>3</sup>Statistical heterogeneity: I² = 63%, likely due to differences in women's management. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Planned early birth compared to expectant management for preterm prelabour rupture of membranes prior to 37 weeks' gestation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004735-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of trials assessing early birth with expectant management in women with PPROM</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gestational age for inclusion (weeks)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Co‐interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fetal lung maturity tested</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0001" title="CoxSM , LevenoKJ . Intentional delivery vs expectant management with preterm ruptured membranes at 30‐34 weeks' gestation. Obstetrics &amp; Gynecology1995;86:875‐9. CoxSM , LevenoKJ , ShermanML , TravisL , DePalmaR . Ruptured membranes at 30 to 34 weeks: intentional delivery vs expectant management. American Journal of Obstetrics and Gynecology1995;172:412. ">Cox 1995</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129</p> <p>(131 babies)</p> <p>61 ED</p> <p>(62 babies)</p> <p>68 EM</p> <p>(69 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0016"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0002" title="Eroiz‐HernandezJ , Trejo‐AcunaMA , Alvarez‐TarinMH . Conservative management of premature membrane rupture in pregnancy of 28‐34 weeks. Aleatory clinical trial [Manejo conservador de ruptura prematura de membranas en embarazos de 28 a 34 semanas. Essayo clinico aleatorio]. Ginecologia y Obstetricia de Mexico1997;65:43‐7. ">Eroiz‐Hernandez 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> <p>30 ED</p> <p>28 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0017"> <li> <p>ED group given fetal lung maturity protocol of 6 doses of 250 mg of intravenous aminophylline every 8 hours </p> </li> <li> <p>EM group managed with the same lung maturity protocol repeated weekly</p> </li> <li> <p>No prophylactic antibiotics</p> </li> <li> <p>Tocolysis if contracting</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes, if positive <b>excluded</b> from randomisation </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0003" title="GariteTJ , FreemanRK , LinzeyEM , BralyPS , DorchesterWL . Prospective randomised study in corticosteroids in the management of premature rupture of the membranes and the premature gestation. American Journal of Obstetrics and Gynecology1981;141(5):508‐15. ">Garite 1981</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> <p>80 ED</p> <p>80 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0018"> <li> <p>Corticosteroids to ED group</p> </li> <li> <p>Tocolysis to ED group if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: if L/S mature <b>excluded</b> from randomisation and delivered </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0004" title="IamsJD , TalbertML , BarrowsH , SachsL . Management of preterm prematurely ruptured membranes: a prospective randomized comparison of observation vs use of steroids and timed delivery. American Journal of Obstetrics and Gynecology1985;151:32‐8. ">Iams 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> <p>38 ED</p> <p>35 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0019"> <li> <p>Corticosteroids to ED group</p> </li> <li> <p>Tocolysis to ED group if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: if mature L/S <b>excluded</b> from randomisation and delivered </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0005" title="KoroveshiG , QirkoR , KoroveshiE , KuliG , KodraN , NurceA , et al. Incidence of sepsis in late preterm babies born from pregnancies complicated with premature preterm rupture of membranes. Journal of Perinatal Medicine2013;41(Suppl 1):Abstract no:622. ">Koroveshi 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>307</p> <p>157 ED</p> <p>150 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0020"> <li> <p>Not mentioned</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0006" title="MercerB , CrockerL , BoeN , SibaiB . Induction versus expectant management in PROM with mature amniotic fluid at 32‐36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;168(1 Pt 2):295. MercerBM , CrockerLG , BoeNM , SibaiBM . Induction vs expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. American Journal of Obstetrics and Gynecology1993;169:775‐82. ">Mercer 1993</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93</p> <p>46 ED</p> <p>47 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0021"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: <b>included</b> if mature L/S </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0007" title="MorrisJ , RobertsCL , BondDM , CrowtherC . Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMT) ‐ a progress report. Journal of Paediatrics and Child Health2012;48(Suppl 1):96. MorrisJA , RobertsCL , PattersonJA , BondDM , CrowtherCA , BowenJR , et al. Immediate delivery versus expectant care in women with preterm prelabour rupture of the membranes close to term (PPROMPT): a multi‐centre randomised controlled trial. Archives of Disease in Childhood2014;99(Suppl 2):A223. MorrisJM , AlgertC , CrowtherC , BondD , BowenJ , RobertsCL . Preterm pre‐labour rupture of the membranes close to term (PPROMT) trial. Journal of Paediatrics and Child Health2014;50(Suppl 1):23‐4. MorrisJM , RobertsCL , BowenJR , PattersonJA , BondDM , AlgertCS , et al. Immediate delivery compared with expectant management after preterm pre‐labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet2016;387(10017):444‐52. MorrisJM , RobertsCL , CrowtherCA , BuchananSL , Henderson‐SmartDJ , SalkeldG . Protocol for the immediate delivery versus expectant care of women with preterm prelabour rupture of the membranes close to term (PPROMT) trial. BMC Pregnancy and Childbirth2006;6:9. ">Morris 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1835</p> <p>923 ED</p> <p>912 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0022"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Corticosteroids according to local protocol</p> </li> <li> <p>Tocolysis according to local protocol</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0008" title="NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. American Journal of Obstetrics and Gynecology1998;178(1):126‐30. NaefRW , AllbertJR , RossEL , WeberM , MartinRW , MorrisonJC . Premature rupture of the membranes at 34‐37 weeks' gestation: aggressive vs conservative management. American Journal of Obstetrics and Gynecology1994;170:340. ">Naef 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> <p>57 ED</p> <p>63 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+ 6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0023"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>Prophylactic antibiotics for all women</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0009" title="NelsonLH , MeisPJ , HatjisCG , ErnestJM , DillardR , ScheyHM . Premature rupture of membranes: a prospective, randomized evaluation of steroids, latent phase, and expectant management. Obstetrics &amp; Gynecology1985; Vol. 66:55‐8. ">Nelson 1985</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> <p>22 ED and steroids</p> <p>22 ED and no steroids</p> <p>24 EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28 to 34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0024"> <li> <p>Corticosteroids only to 1 of ED groups</p> </li> <li> <p>Tocolysis to ED groups if required</p> </li> <li> <p>No prophylactic antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0010" title="SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Obstetrics &amp; Gynecology1987; Vol. 69:196‐201. SpinnatoJA , ShaverDC , BrayEM , LipshitzJ . Preterm premature rupture of the membranes with fetal pulmonary maturity present: a prospective study. Proceedings of 6th Annual Meeting of the Society of Perinatal Obstetricians; 1986 Jan 30‐Feb 1; San Antonio, Texas, USA. 1986:82. ">Spinnato 1987</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> <p>26 to ED</p> <p>21 to EM</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 to 36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0025"> <li> <p>No corticosteroids</p> </li> <li> <p>No tocolysis</p> </li> <li> <p>No antibiotics</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Yes: <b>included</b> if mature L/S </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0011" title="MolBW , VijgenS , OpmeerB , BijlengaD , AkerboomB , VanWijngaardenW , et al. Economic analysis of induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial ISRCTN29313500). American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S336. Van derHamDP , NijhuisJG , MolBW , VanBeekJJ , OpmeerBC , BijlengaD , et al. Induction of labour versus expectant management in women with preterm prelabour rupture of membranes between 34 and 37 weeks (the PPROMEXIL‐trial). BMC Pregnancy and Childbirth2007;7:11. Van derHamDP , VijgenSMC , NijhuisJG , VanBeekJJ , OpmeerBC , MulderALM , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial. PLoS Medicine2012;9(4):e1001208. Van derHeydenJ , WillekesC , OudijkM , PorathM , DuvekotH , BloemenkampKWM , et al. Behavioural and developmental outcome of neonates at 2 years of age after preterm prelabor rupture of membranes: follow up of the PPROMEXIL trial. American Journal of Obstetrics and Gynecology2014;210(1 Suppl):S349‐50. Van derHeydenJL , WillekesC , VanBaarAL , VanWassenaer‐LeemhuisAG , PajkrtE , OudijkMA , et al. Behavioural and neurodevelopmental outcome of 2‐year‐old children after preterm premature rupture of membranes: follow‐up of a randomised clinical trial comparing induction of labour and expectant management. European Journal of Obstetrics, Gynecology, and Reproductive Biology2015;194:17‐23. WillekesC . Preterm premature rupture of membranes between 34 and 37 weeks: expectant management versus induction of labour (planned trial). Current Controlled Trials (www.controlled‐trials.com) (accessed 15 February 2007)2007. ">Van der Ham 2012a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>532</p> <p>(538 babies)</p> <p>266 ED</p> <p>(268 babies)</p> <p>266 EM</p> <p>(270 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0026"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Tocolysis dependent on local protocol</p> </li> <li> <p>Corticosteroids given in PPROM &lt; 34 weeks' gestational age</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004735-bbs2-0012" title="TajikP , Van derHamDP , ZafarmandMH , HofMHP , MorrisJ , FranssenMTM , et al. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG: an international journal of obstetrics and gynaecology2014;121:1263‐73. Van derHamD , Van derHeijdenJ , OpmeerB , VanBeekH , WillekesC , MulderT , et al. Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks ‐ the PPROMEXIL‐2 trial (ISRCTN05689407). American Journal of Obstetrics and Gynecology2012;206(Suppl 1):S8‐9. Van derHamDP , Van derHeydenJL , OpmeerBC , MulderAL , MoonenRM , VanBeekJH , et al. Management of late‐preterm premature rupture of membranes: the PPROMEXIL‐2 trial. American Journal of Obstetrics and Gynecology2012;207(4):276.e1‐e10. VijgenSM , Van derHamDP , BijlengaD , VanBeekJJ , BloemenkampKW , KweeA , et al. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial). Acta Obstetricia et Gynecologica Scandinavica2014; Vol. 93, issue 4:374‐81. ">Van der Ham 2012b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>195</p> <p>(198 babies)</p> <p>100 ED</p> <p>(100 babies)</p> <p>95 EM</p> <p>(98 babies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34 to 36<sup>+6</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD004735-list-0027"> <li> <p>Antibiotics according to local protocol</p> </li> <li> <p>Tocolysis dependent on local protocol</p> </li> <li> <p>Corticosteroids given in PPROM &lt; 34 weeks' gestational age</p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>ED: early delivery<br/> EM: expectant management<br/> L/S: lecithin‐sphingomyelin </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of trials assessing early birth with expectant management in women with PPROM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/full#CD004735-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004735-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any planned birth versus expectant management: by type</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal infection/sepsis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal infection confirmed with positive blood culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2925</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.70, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.05, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.11, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Perinatal mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3319</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.89, 3.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Intrauterine death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [0.13, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Cord prolapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2722</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.33, 4.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.57, ‐0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Neonatal death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.17, 5.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Suspected neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>829</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.36, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal treatment with antibiotics <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2638</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.63, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Need for ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.02, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Duration of oxygen therapy (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.05 [‐6.92, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Umbilical cord arterial pH <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.07, 0.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐47.10 [‐96.00, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Apgar score less than 7 at 5 minutes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2700</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.54, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Abnormality on cerebral ultrasound <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.90 [0.52, 6.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>707</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.14, 6.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Cerebroventricular haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1095</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.40, 3.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Necrotising enterocolitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2842</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.25, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Severe respiratory distress <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [0.80, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Admission to neonatal intensive care unit <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.16 [1.08, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Length of stay in neonatal intensive care unit (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐1.62, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Duration (days) from birth to neonatal hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2832</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [‐0.28, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">25 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.26, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">26 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.00, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">27 Postpartum fever <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.26, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">28 Placental abruption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.36, 3.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">29 Induction of labour <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [2.01, 2.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">30 Use of epidural/spinal anaesthesia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.99, 1.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">31 Vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.91, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">32 Operative vaginal birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2685</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.67, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">33 Caesarean section for fetal distress <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2918</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.66, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">34 Duration (days) of maternal hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2848</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐2.45, ‐1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">35 Duration (days) of antenatal hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.30 [‐9.67, ‐2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">36 Duration (days) of maternal hospitalisation (excluding trials with antenatal discharge) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.64 [‐3.06, ‐0.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">37 Time (hours) from randomisation to birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐79.48 [‐88.27, ‐70.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">38 Disability at 2 years, abnormal CBCL <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.26, 1.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">39 Disability at 2 years, abnormal ASQ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>228</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.35, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">40 Maternal satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">41 Breastfeeding &gt; 12 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any planned birth versus expectant management: by type</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004735-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by corticosteroid usage)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3652</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.68, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.48, 2.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2850</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.64, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.25, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal infection confirmed with positive culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2939</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.74, 2.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.18, 2.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2680</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.85, 3.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3646</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.07, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>495</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.96, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2844</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.01, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.55, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.11, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>493</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.00, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2844</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.10, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.51, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.33, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.22, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.36, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.00, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 No antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.32, 5.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Some antenatal corticosteroids</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.64 [0.99, 2.72]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by corticosteroid usage)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004735-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.47, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.74, 3.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Not specified (wider span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.65, 6.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal infection confirmed with positive culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2925</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.70, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2691</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.52, 2.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.52, 5.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Not specified (wider span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [0.27, 8.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.05, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [1.10, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>490</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.84, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Not specified (wider span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.27, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.11, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2992</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [1.05, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>488</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [1.08, 1.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Not specified (wider span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.45, 3.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.33, 0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>847</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.26 [0.12, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.45, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Not specified (wider span)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.15, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.00, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Greater than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.10, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Less than 34 weeks' gestation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.23 [1.29, 3.84]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by gestational age for inclusion in trial)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004735-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by antibiotic use)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1702</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.42, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>880</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.81, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>736</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.30, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.25, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal infection confirmed with positive culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2925</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.70, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [0.01, 2.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [0.62, 4.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.62, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.06, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.23, 5.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>630</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.85, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.48 [1.10, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.55, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [1.14, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.34, 6.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [1.08, 1.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2565</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [1.12, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Not specified</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.51, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.26, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [0.01, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>511</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.34, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.15, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.00, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Prophylactic antibiotics not used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.23 [1.29, 3.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Some prophylactic antibiotics used</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2562</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.10, 1.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by antibiotic use)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004735-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by timing of early delivery)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Neonatal infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.66, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.41, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2930</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.64, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.25, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Neonatal infection confirmed with positive culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2925</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.70, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.18, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2712</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.44 [0.76, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Respiratory distress syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3622</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.06, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>391</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.65, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2924</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.37 [1.10, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.55, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Caesarean section <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [1.11, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.90, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2924</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.10, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.51, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Chorioamnionitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1358</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.26, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>342</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.10, 0.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.41, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Endometritis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2980</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [1.00, 2.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Less than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>129</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [0.29, 9.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Greater than 24 hours from randomisation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2851</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.60 [0.98, 2.63]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Any planned birth versus expectant management (subgroup analysis by timing of early delivery)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004735.pub4/references#CD004735-tbl-0007">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004735.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004735-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004735-note-0008">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD004735-note-0013">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD004735-note-0007">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD004735-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD004735-note-0004">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD004735-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD004735-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD004735-note-0003">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004735\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004735\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004735\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004735\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004735\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=PSzzz2OT&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004735.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004735.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004735.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004735.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004735.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718763250"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004735.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718763254"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004735.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd8452b1f935f',t:'MTc0MDcxODc2My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 